Interleukin-6	B-protein
production	O
in	O
hemorrhagic	O
shock	O
is	O
accompanied	O
by	O
neutrophil	O
recruitment	O
and	O
lung	O
injury	O
.	O

Hemorrhagic	O
shock	O
(	O
HS	O
)	O
initiates	O
an	O
inflammatory	O
cascade	O
that	O
includes	O
the	O
production	O
of	O
cytokines	B-protein
and	O
recruitment	O
of	O
neutrophils	B-cell_type
(	O
PMN	B-cell_type
)	O
and	O
may	O
progress	O
to	O
organ	O
failure	O
,	O
inducing	O
acute	O
respiratory	O
distress	O
syndrome	O
(	O
ARDS	O
)	O
.	O

To	O
examine	O
the	O
hypothesis	O
that	O
interleukin-6	B-protein
(	O
IL-6	B-protein
)	O
contributes	O
to	O
PMN	O
infiltration	O
and	O
lung	O
damage	O
in	O
HS	O
,	O
we	O
examined	O
the	O
lungs	O
of	O
rats	O
subjected	O
to	O
unresuscitated	O
and	O
resuscitated	O
HS	O
for	O
the	O
production	O
of	O
IL-6	B-protein
and	O
activation	O
of	O
Stat3	B-protein
.	O

Using	O
semiquantitative	O
RT-PCR	O
,	O
we	O
found	O
a	O
striking	O
increase	O
in	O
IL-6	B-RNA
mRNA	I-RNA
levels	O
only	O
in	O
resuscitated	O
HS	O
,	O
with	O
peak	O
levels	O
observed	O
1	O
h	O
after	O
initiation	O
of	O
resuscitation	O
.	O

Increased	O
IL-6	B-protein
protein	O
expression	O
was	O
localized	O
to	O
bronchial	B-cell_type
and	I-cell_type
alveolar	I-cell_type
cells	I-cell_type
.	O

Electrophoretic	O
mobility	O
shift	O
assay	O
of	O
protein	O
extracts	O
from	O
shock	O
lungs	O
exhibited	O
an	O
increase	O
in	O
Stat3	B-protein
activation	O
with	O
kinetics	O
similar	O
to	O
IL-6	B-RNA
mRNA	I-RNA
.	O

In	O
situ	O
DNA	O
binding	O
assay	O
determined	O
Stat3	B-protein
activation	O
predominantly	O
within	O
alveoli	O
.	O

Intratracheal	O
instillation	O
of	O
IL-6	B-protein
alone	O
into	O
normal	O
rats	O
resulted	O
in	O
PMN	O
infiltration	O
into	O
lung	O
interstitium	O
and	O
alveoli	O
,	O
marked	O
elevation	O
of	O
bronchoalveolar	O
lavage	O
cellularity	O
,	O
and	O
increased	O
wet-to-dry	O
ratio	O
.	O

These	O
findings	O
indicate	O
that	O
IL-6	B-protein
production	O
and	O
Stat3	B-protein
activation	O
occur	O
early	O
in	O
HS	O
and	O
may	O
contribute	O
to	O
PMN-mediated	O
lung	O
injury	O
,	O
including	O
ARDS	O
after	O
HS	O
.	O

Interleukin-6	NULL
production	NULL
in	NULL
hemorrhagic	NULL
shock	NULL
is	NULL
accompanied	NULL
by	NULL
neutrophil	NULL
recruitment	NULL
and	NULL
lung	NULL
injury	NULL
CHRISTIAN	NULL
HIERHOLZER	NULL
,	NULL
*	NULL
JORG	NULL
C.	NULL
KALFE	NULL
,	NULL
'	NULL
LAUREL	NULL
OMERT	NULL
,	NULL
!	NULL

KATSUHIKO	NULL
TSUKADA	NULL
,	NULL
!	NULL

J.	NULL
ERIC	NULL
LOEFFERT	NULL
,	NULL
*	NULL
SIMON	NULL
C.	NULL
WATKINS,2	NULL
TIMOTHY	NULL
R.	NULL
BILLIAR	NULL
,	NULL
*	NULL
AND	NULL
DAVID	NULL
J.	NULL
TWEARDY®5	NULL
Departments	NULL
of	NULL
'Surgery	NULL
,	NULL
``	NULL
Cell	NULL
Biology	NULL
,	NULL
Medicine	NULL
,	NULL
and	NULL
*Molecular	NULL
Genetics	NULL
and	NULL
Biochemistry	NULL
,	NULL
University	NULL
of	NULL
Pittsburgh	NULL
School	NULL
of	NULL
Medicine	NULL
and	NULL
®University	NULL
of	NULL
Pittsburgh	NULL
Cancer	NULL
Institute	NULL
,	NULL
University	NULL
of	NULL
Pittsburgh	NULL
Medical	NULL
Center	NULL
,	NULL
Pittsburgh	NULL
,	NULL
Pennsylvania	NULL
15213	NULL
Hierholzer	NULL
,	NULL
Christian	NULL
,	NULL
Jorg	NULL
C.	NULL
Kalff	NULL
,	NULL
Laurel	NULL
Omert	NULL
,	NULL
Katsuhiko	NULL
Tsukada	NULL
,	NULL
J.	NULL
Eric	NULL
Loeffert	NULL
,	NULL
Simon	NULL
C.	NULL
Watkins	NULL
,	NULL
Timothy	NULL
R.	NULL
Billiar	NULL
,	NULL
and	NULL
David	NULL
J.	NULL
Tweardy	NULL
.	NULL

Interleukin-6	NULL
production	NULL
in	NULL
hemorrhagic	NULL
shock	NULL
is	NULL
accompanied	NULL
by	NULL
neutrophil	NULL
recruitment	NULL
and	NULL
lung	NULL
injury	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Physiol	NULL
.	NULL

275	NULL
(	NULL
Lung	NULL
Cell	NULL
.	NULL

Mol	NULL
.	NULL

Physiol	NULL
.	NULL

19	NULL
)	NULL
L611-L621	NULL
,	NULL
1998.-Hemorrhagic	NULL
shock	NULL
(	NULL
HS	NULL
)	NULL
initiates	NULL
an	NULL
inflammatory	NULL
cascade	NULL
that	NULL
includes	NULL
the	NULL
production	NULL
of	NULL
cytokines	NULL
and	NULL
recruitment	NULL
of	NULL
neutrophils	NULL
(	NULL
PMN	NULL
)	NULL
and	NULL
may	NULL
progress	NULL
to	NULL
organ	NULL
failure	NULL
,	NULL
inducing	NULL
acute	NULL
respiratory	NULL
distress	NULL
syndrome	NULL
(	NULL
ARDS	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
hypothesis	NULL
that	NULL
interleukin-6	NULL
(	NULL
IL-6	NULL
)	NULL
contributes	NULL
to	NULL
PMN	NULL
infiltration	NULL
and	NULL
lung	NULL
damage	NULL
in	NULL
HS	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
lungs	NULL
of	NULL
rats	NULL
subjected	NULL
to	NULL
unresuscitated	NULL
and	NULL
resuscitated	NULL
HS	NULL
for	NULL
the	NULL
production	NULL
of	NULL
IL-6	NULL
and	NULL
activation	NULL
of	NULL
Stat8	NULL
.	NULL

Using	NULL
semiquantitative	NULL
RT-PCR	NULL
,	NULL
we	NULL
found	NULL
a	NULL
striking	NULL
increase	NULL
in	NULL
IL-6	NULL
mRNA	NULL
levels	NULL
only	NULL
in	NULL
resuscitated	NULL
HS	NULL
,	NULL
with	NULL
peak	NULL
levels	NULL
observed	NULL
1	NULL
h	NULL
after	NULL
initiation	NULL
of	NULL
resuscitation	NULL
.	NULL

Increased	NULL
IL-6	NULL
protein	NULL
expression	NULL
was	NULL
localized	NULL
to	NULL
bronchial	NULL
and	NULL
alveolar	NULL
cells	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
of	NULL
protein	NULL
extracts	NULL
from	NULL
shock	NULL
lungs	NULL
exhibited	NULL
an	NULL
increase	NULL
in	NULL
Stat3	NULL
activation	NULL
with	NULL
kinetics	NULL
similar	NULL
to	NULL
IL-6	NULL
mRNA	NULL
.	NULL

In	NULL
situ	NULL
DNA	NULL
binding	NULL
assay	NULL
determined	NULL
Stat3	NULL
activation	NULL
predominantly	NULL
within	NULL
alveoli	NULL
.	NULL

Intratracheal	NULL
instillation	NULL
of	NULL
IL-6	NULL
alone	NULL
into	NULL
normal	NULL
rats	NULL
resulted	NULL
in	NULL
PMN	NULL
infiltration	NULL
into	NULL
lung	NULL
interstitium	NULL
and	NULL
alveoli	NULL
,	NULL
marked	NULL
elevation	NULL
of	NULL
bronchoalveolar	NULL
lavage	NULL
cellularity	NULL
,	NULL
and	NULL
increased	NULL
wet-to-dry	NULL
ratio	NULL
.	NULL

These	NULL
findings	NULL
indicate	NULL
that	NULL
IL-6	NULL
production	NULL
and	NULL
Stat3	NULL
activation	NULL
occur	NULL
early	NULL
in	NULL
HS	NULL
and	NULL
may	NULL
contribute	NULL
to	NULL
PMN-mediated	NULL
lung	NULL
injury	NULL
,	NULL
including	NULL
ARDS	NULL
after	NULL
HS	NULL
.	NULL

cytokines	NULL
;	NULL
acute	NULL
inflammation	NULL
;	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
;	NULL
acute	NULL
respiratory	NULL
distress	NULL
syndrome	NULL
HEMORRHAGIC	NULL
SHOCK	NULL
(	NULL
HS	NULL
)	NULL
initiates	NULL
a	NULL
cascade	NULL
of	NULL
inflammatory	NULL
events	NULL
after	NULL
successful	NULL
resuscitation	NULL
that	NULL
may	NULL
result	NULL
in	NULL
organ	NULL
impairment	NULL
,	NULL
including	NULL
acute	NULL
respiratory	NULL
distress	NULL
syndrome	NULL
(	NULL
ARDS	NULL
)	NULL
and	NULL
increased	NULL
mortal-ity	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
resuscitated	NULL
HS	NULL
in	NULL
rats	NULL
results	NULL
in	NULL
acute	NULL
lung	NULL
injury	NULL
manifested	NULL
by	NULL
infiltration	NULL
of	NULL
polymorphonuclear	NULL
neutrophils	NULL
(	NULL
PMN	NULL
)	NULL
into	NULL
the	NULL
interstitium	NULL
and	NULL
alveoli	NULL
,	NULL
pulmonary	NULL
edema	NULL
,	NULL
and	NULL
hyp-oxia	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Chemokines	NULL
of	NULL
the	NULL
C-X-C	NULL
class	NULL
,	NULL
especially	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
-8	NULL
,	NULL
have	NULL
been	NULL
demonstrated	NULL
to	NULL
be	NULL
key	NULL
mediators	NULL
of	NULL
PMN	NULL
infiltration	NULL
in	NULL
HS	NULL
(	NULL
20	NULL
,	NULL
28	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
IL-6	NULL
participates	NULL
in	NULL
the	NULL
recruitment	NULL
of	NULL
PMN	NULL
into	NULL
tissue	NULL
sites	NULL
by	NULL
induction	NULL
of	NULL
IL-8	NULL
(	NULL
26	NULL
)	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

The	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

1040-0605/98	NULL
$	NULL
5.00	NULL
Copyright	NULL
©	NULL
1998	NULL
the	NULL
American	NULL
Physiological	NULL
Society	NULL
The	NULL
systemic	NULL
response	NULL
to	NULL
inflammation	NULL
includes	NULL
the	NULL
production	NULL
of	NULL
IL-6	NULL
,	NULL
which	NULL
signals	NULL
through	NULL
activation	NULL
of	NULL
proteins	NULL
that	NULL
serve	NULL
the	NULL
dual	NULL
function	NULL
of	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
(	NULL
STAT	NULL
)	NULL
(	NULL
18	NULL
)	NULL
.	NULL

We	NULL
previously	NULL
demonstrated	NULL
activation	NULL
of	NULL
STAT	NULL
proteins	NULL
,	NULL
particularly	NULL
Stat3	NULL
,	NULL
in	NULL
the	NULL
lungs	NULL
of	NULL
animals	NULL
subjected	NULL
to	NULL
HS	NULL
and	NULL
that	NULL
levels	NULL
of	NULL
Stat3	NULL
activity	NULL
increased	NULL
with	NULL
increasing	NULL
severity	NULL
of	NULL
shock	NULL
(	NULL
13	NULL
)	NULL
.	NULL

The	NULL
current	NULL
study	NULL
was	NULL
designed	NULL
to	NULL
determine	NULL
if	NULL
IL-6	NULL
production	NULL
occurs	NULL
in	NULL
our	NULL
rat	NULL
model	NULL
of	NULL
HS	NULL
where	NULL
it	NULL
may	NULL
contribute	NULL
to	NULL
PMN	NULL
infiltration	NULL
and	NULL
Stat3	NULL
activation	NULL
.	NULL

We	NULL
report	NULL
here	NULL
that	NULL
levels	NULL
of	NULL
IL-6	NULL
mRNA	NULL
increased	NULL
with	NULL
increased	NULL
duration	NULL
of	NULL
the	NULL
ischemic	NULL
phase	NULL
of	NULL
resuscitated	NULL
shock	NULL
,	NULL
similar	NULL
to	NULL
our	NULL
findings	NULL
regarding	NULL
Stat3	NULL
activity	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
levels	NULL
of	NULL
IL-6	NULL
mRNA	NULL
and	NULL
Stat3	NULL
activity	NULL
were	NULL
increased	NULL
above	NULL
control	NULL
animals	NULL
only	NULL
in	NULL
resuscitated	NULL
HS	NULL
animals	NULL
.	NULL

Furthermore	NULL
,	NULL
induction	NULL
of	NULL
IL-6	NULL
mRNA	NULL
as	NULL
well	NULL
as	NULL
the	NULL
activation	NULL
of	NULL
Stat3	NULL
occurred	NULL
simultaneously	NULL
after	NULL
resuscitation	NULL
,	NULL
with	NULL
levels	NULL
of	NULL
both	NULL
peaking	NULL
1	NULL
h	NULL
after	NULL
the	NULL
onset	NULL
of	NULL
resuscitation	NULL
.	NULL

To	NULL
test	NULL
the	NULL
hypothesis	NULL
that	NULL
IL-6	NULL
protein	NULL
in	NULL
the	NULL
distal	NULL
airways	NULL
of	NULL
the	NULL
lung	NULL
will	NULL
cause	NULL
PMN	NULL
recruitment	NULL
and	NULL
lung	NULL
injury	NULL
,	NULL
we	NULL
administered	NULL
IL-6	NULL
by	NULL
intratracheal	NULL
instillation	NULL
into	NULL
the	NULL
lungs	NULL
of	NULL
anesthetized	NULL
rats	NULL
.	NULL

IL-6	NULL
instillation	NULL
resulted	NULL
in	NULL
increased	NULL
bronchoalveolar	NULL
lavage	NULL
(	NULL
BAL	NULL
)	NULL
fluid	NULL
cellularity	NULL
,	NULL
accumulation	NULL
of	NULL
PMN	NULL
into	NULL
widened	NULL
interstitial	NULL
and	NULL
alveolar	NULL
spaces	NULL
,	NULL
and	NULL
increased	NULL
wet-to-dry	NULL
ratios	NULL
to	NULL
levels	NULL
observed	NULL
previously	NULL
in	NULL
animals	NULL
subjected	NULL
to	NULL
HS	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
IL-6	NULL
is	NULL
produced	NULL
in	NULL
the	NULL
lung	NULL
in	NULL
HS	NULL
where	NULL
it	NULL
contributes	NULL
to	NULL
Stat3	NULL
activation	NULL
,	NULL
PMN	NULL
infiltration	NULL
,	NULL
and	NULL
lung	NULL
injury	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Animals	NULL
.	NULL

These	NULL
studies	NULL
were	NULL
approved	NULL
by	NULL
the	NULL
University	NULL
of	NULL
Pittsburgh	NULL
Institutional	NULL
Review	NULL
Board	NULL
for	NULL
animal	NULL
experimentation	NULL
and	NULL
conform	NULL
to	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
guidelines	NULL
for	NULL
the	NULL
care	NULL
and	NULL
use	NULL
of	NULL
laboratory	NULL
animals	NULL
.	NULL

Fasted	NULL
male	NULL
Sprague-Dawley	NULL
rats	NULL
(	NULL
Charles	NULL
River	NULL
Breeding	NULL
Laboratory	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
were	NULL
used	NULL
for	NULL
all	NULL
phases	NULL
of	NULL
these	NULL
studies	NULL
.	NULL

HS	NULL
protocols	NULL
.	NULL

For	NULL
initial	NULL
anesthesia	NULL
,	NULL
penthrane	NULL
inhalation	NULL
was	NULL
used	NULL
.	NULL

The	NULL
animals	NULL
were	NULL
intubated	NULL
orally	NULL
with	NULL
a	NULL
14-gauge	NULL
cannula	NULL
.	NULL

The	NULL
right	NULL
carotid	NULL
artery	NULL
and	NULL
left	NULL
jugular	NULL
vein	NULL
were	NULL
cannulated	NULL
with	NULL
21-gauge	NULL
tubing	NULL
after	NULL
surgical	NULL
preparation	NULL
and	NULL
isolation	NULL
.	NULL

The	NULL
cannulas	NULL
,	NULL
syringes	NULL
,	NULL
and	NULL
tubing	NULL
were	NULL
flushed	NULL
with	NULL
heparin	NULL
sodium	NULL
(	NULL
1,000	NULL
U/ml	NULL
)	NULL
before	NULL
all	NULL
procedures	NULL
.	NULL

Arterial	NULL
blood	NULL
pressure	NULL
was	NULL
continuously	NULL
monitored	NULL
with	NULL
a	NULL
Spacelab	NULL
514	NULL
multimonitor	NULL
(	NULL
Spacelabs	NULL
,	NULL
Hillsboro	NULL
,	NULL
OR	NULL
)	NULL
.	NULL

A	NULL
Harvard	NULL
small-animal	NULL
ventilator	NULL
(	NULL
Braintree	NULL
Scientific	NULL
,	NULL
Braintree	NULL
,	NULL
MA	NULL
)	NULL
was	NULL
used	NULL
to	NULL
administer	NULL
a	NULL
2.5-ml	NULL
tidal	NULL
volume	NULL
of	NULL
room	NULL
air	NULL
at	NULL
72	NULL
strokes/min	NULL
.	NULL

After	NULL
vascular	NULL
cannulation	NULL
,	NULL
the	NULL
animals	NULL
received	NULL
intravenous	NULL
anesthesia	NULL
(	NULL
50	NULL
mg/kg	NULL
pentobar-bital	NULL
sodium	NULL
)	NULL
.	NULL

L611	NULL
Downloaded	NULL
from	NULL
www.physiclogy.org/journal/ajplung	NULL
(	NULL
173.236.240.127	NULL
)	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

L612	NULL
Two	NULL
HS	NULL
protocols	NULL
were	NULL
performed	NULL
:	NULL
HS	NULL
without	NULL
resuscitation	NULL
and	NULL
HS	NULL
with	NULL
resuscitation	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
unresuscitated	NULL
HS	NULL
protocol	NULL
was	NULL
carried	NULL
out	NULL
to	NULL
the	NULL
predefined	NULL
end	NULL
points	NULL
of	NULL
compensated	NULL
,	NULL
decompensated	NULL
,	NULL
and	NULL
irreversible	NULL
shock	NULL
.	NULL

After	NULL
the	NULL
initial	NULL
bleed	NULL
of	NULL
2.25	NULL
ml/100	NULL
g	NULL
body	NULL
wt	NULL
,	NULL
mean	NULL
arterial	NULL
pressure	NULL
(	NULL
MAP	NULL
)	NULL
dropped	NULL
sharply	NULL
and	NULL
then	NULL
slowly	NULL
stabilized	NULL
.	NULL

In	NULL
compensated	NULL
shock	NULL
(	NULL
1	NULL
h	NULL
of	NULL
ischemia	NULL
)	NULL
,	NULL
additional	NULL
blood	NULL
was	NULL
withdrawn	NULL
to	NULL
maintain	NULL
MAP	NULL
at	NULL
40	NULL
mmHg	NULL
for	NULL
1	NULL
h	NULL
,	NULL
and	NULL
no	NULL
shed	NULL
blood	NULL
was	NULL
returned	NULL
(	NULL
0	NULL
%	NULL
shed	NULL
blood	NULL
return	NULL
,	NULL
SBR	NULL
)	NULL
.	NULL

In	NULL
decompensated	NULL
shock	NULL
(	NULL
2.5	NULL
h	NULL
of	NULL
ischemia	NULL
)	NULL
,	NULL
the	NULL
MAP	NULL
was	NULL
maintained	NULL
at	NULL
40	NULL
mmHg	NULL
for	NULL
2.5	NULL
h	NULL
and	NULL
required	NULL
35	NULL
%	NULL
of	NULL
the	NULL
shed	NULL
blood	NULL
to	NULL
be	NULL
returned	NULL
(	NULL
35	NULL
%	NULL
SBR	NULL
)	NULL
.	NULL

In	NULL
irreversible	NULL
shock	NULL
(	NULL
8.5	NULL
h	NULL
of	NULL
ischemia	NULL
)	NULL
,	NULL
MAP	NULL
was	NULL
maintained	NULL
at	NULL
40	NULL
mmHg	NULL
for	NULL
3.5	NULL
h	NULL
and	NULL
required	NULL
70	NULL
%	NULL
of	NULL
the	NULL
shed	NULL
blood	NULL
to	NULL
be	NULL
returned	NULL
(	NULL
70	NULL
%	NULL
SBR	NULL
)	NULL
.	NULL

Animals	NULL
in	NULL
the	NULL
unresuscitated	NULL
HS	NULL
protocol	NULL
were	NULL
killed	NULL
at	NULL
the	NULL
end	NULL
of	NULL
the	NULL
ischemic	NULL
phase	NULL
.	NULL

Time-matched	NULL
sham	NULL
control	NULL
animals	NULL
underwent	NULL
all	NULL
preparations	NULL
and	NULL
monitoring	NULL
procedures	NULL
but	NULL
were	NULL
not	NULL
bled	NULL
.	NULL

Animals	NULL
were	NULL
randomly	NULL
subjected	NULL
to	NULL
either	NULL
the	NULL
shock	NULL
or	NULL
sham	NULL
protocol	NULL
.	NULL

There	NULL
were	NULL
three	NULL
to	NULL
five	NULL
animals	NULL
in	NULL
each	NULL
shock	NULL
and	NULL
sham	NULL
group	NULL
.	NULL

In	NULL
the	NULL
resuscitated	NULL
HS	NULL
protocol	NULL
,	NULL
animal	NULL
preparation	NULL
and	NULL
hemorrhage	NULL
were	NULL
carried	NULL
out	NULL
as	NULL
in	NULL
the	NULL
unresuscitated	NULL
protocol	NULL
to	NULL
the	NULL
defined	NULL
end	NULL
points	NULL
:	NULL
for	NULL
the	NULL
compensated	NULL
shock	NULL
(	NULL
1	NULL
h	NULL
of	NULL
ischemia	NULL
)	NULL
groups	NULL
to	NULL
compensation	NULL
end	NULL
point	NULL
with	NULL
0	NULL
%	NULL
SBR	NULL
and	NULL
for	NULL
the	NULL
decompensated	NULL
shock	NULL
(	NULL
2.5	NULL
h	NULL
of	NULL
ischemia	NULL
)	NULL
groups	NULL
to	NULL
midcompensation	NULL
phase	NULL
with	NULL
35	NULL
%	NULL
SBR	NULL
.	NULL

Once	NULL
the	NULL
animals	NULL
had	NULL
attained	NULL
these	NULL
points	NULL
in	NULL
the	NULL
protocol	NULL
,	NULL
they	NULL
were	NULL
resusci-tated	NULL
,	NULL
and	NULL
the	NULL
MAP	NULL
was	NULL
normalized	NULL
using	NULL
shed	NULL
blood	NULL
plus	NULL
two	NULL
times	NULL
the	NULL
shed	NULL
blood	NULL
volume	NULL
in	NULL
lactated	NULL
Ringer	NULL
solution	NULL
.	NULL

Once	NULL
the	NULL
animal	NULL
had	NULL
recovered	NULL
,	NULL
all	NULL
cannulas	NULL
were	NULL
removed	NULL
,	NULL
and	NULL
the	NULL
incision	NULL
was	NULL
closed	NULL
.	NULL

Rats	NULL
were	NULL
killed	NULL
from	NULL
1	NULL
to	NULL
8	NULL
h	NULL
after	NULL
the	NULL
initiation	NULL
of	NULL
resuscitation	NULL
.	NULL

Time-matched	NULL
sham	NULL
animals	NULL
again	NULL
served	NULL
as	NULL
controls	NULL
,	NULL
and	NULL
there	NULL
were	NULL
four	NULL
rats	NULL
in	NULL
each	NULL
group	NULL
at	NULL
each	NULL
time	NULL
point	NULL
.	NULL

The	NULL
irreversible	NULL
shock	NULL
group	NULL
(	NULL
70	NULL
%	NULL
SBR	NULL
)	NULL
was	NULL
excluded	NULL
from	NULL
the	NULL
resuscitation	NULL
protocol	NULL
because	NULL
animals	NULL
subjected	NULL
to	NULL
70	NULL
%	NULL
SBR	NULL
could	NULL
not	NULL
be	NULL
resuscitated	NULL
.	NULL

IL-6	NULL
instillation	NULL
into	NULL
the	NULL
lungs	NULL
of	NULL
normal	NULL
animals	NULL
.	NULL

Recombi-nant	NULL
human	NULL
IL-6	NULL
was	NULL
obtained	NULL
from	NULL
Genzyme	NULL
(	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

The	NULL
specific	NULL
activity	NULL
was	NULL
8.1	NULL
X	NULL
10	NULL
``	NULL
U/mg	NULL
as	NULL
determined	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

Endotoxin	NULL
levels	NULL
were	NULL
0.102	NULL
ng/ug	NULL
as	NULL
determined	NULL
using	NULL
a	NULL
kinetic-chromogenic	NULL
method	NULL
.	NULL

IL-6	NULL
was	NULL
administered	NULL
by	NULL
intratracheal	NULL
injection	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
14	NULL
)	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
male	NULL
Sprague-Dawley	NULL
rats	NULL
were	NULL
subjected	NULL
to	NULL
instillation	NULL
of	NULL
IL-6	NULL
or	NULL
saline	NULL
fluid	NULL
by	NULL
intratracheal	NULL
injection	NULL
.	NULL

Animals	NULL
were	NULL
intubated	NULL
orally	NULL
.	NULL

To	NULL
prepare	NULL
a	NULL
surfac-tant-containing	NULL
vehicle	NULL
for	NULL
IL-6	NULL
instillation	NULL
,	NULL
20	NULL
ml	NULL
of	NULL
saline	NULL
were	NULL
used	NULL
to	NULL
lavage	NULL
the	NULL
lung	NULL
of	NULL
a	NULL
normal	NULL
rat	NULL
.	NULL

The	NULL
lavage	NULL
fluid	NULL
was	NULL
centrifuged	NULL
(	NULL
2,500	NULL
g	NULL
,	NULL
5	NULL
min	NULL
)	NULL
to	NULL
remove	NULL
cells	NULL
and	NULL
debris	NULL
.	NULL

IL-6	NULL
doses	NULL
(	NULL
0	NULL
,	NULL
10	NULL
,	NULL
30	NULL
,	NULL
100	NULL
,	NULL
or	NULL
300	NULL
ng	NULL
)	NULL
were	NULL
diluted	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
cell-free	NULL
lavage	NULL
fluid	NULL
and	NULL
injected	NULL
into	NULL
the	NULL
trachea	NULL
of	NULL
anesthetized	NULL
animals	NULL
followed	NULL
by	NULL
three	NULL
strokes	NULL
of	NULL
air	NULL
with	NULL
a	NULL
3-ml	NULL
syringe	NULL
.	NULL

After	NULL
instillation	NULL
and	NULL
recovery	NULL
from	NULL
the	NULL
anesthesia	NULL
,	NULL
all	NULL
rats	NULL
were	NULL
active	NULL
and	NULL
alert	NULL
in	NULL
their	NULL
cages	NULL
.	NULL

Animals	NULL
were	NULL
killed	NULL
at	NULL
2	NULL
,	NULL
4	NULL
,	NULL
8	NULL
,	NULL
12	NULL
,	NULL
24	NULL
,	NULL
and	NULL
48	NULL
h	NULL
after	NULL
IL-6	NULL
instillation	NULL
.	NULL

Isolation	NULL
of	NULL
lungs	NULL
and	NULL
cells	NULL
and	NULL
measurement	NULL
of	NULL
lung	NULL
injury	NULL
.	NULL

The	NULL
rats	NULL
subjected	NULL
to	NULL
the	NULL
HS	NULL
protocols	NULL
were	NULL
killed	NULL
at	NULL
the	NULL
completion	NULL
of	NULL
each	NULL
experiment	NULL
.	NULL

After	NULL
the	NULL
carcasses	NULL
were	NULL
flushed	NULL
with	NULL
cold	NULL
(	NULL
4°C	NULL
)	NULL
isotonic	NULL
saline	NULL
solution	NULL
,	NULL
the	NULL
left	NULL
lung	NULL
was	NULL
removed	NULL
and	NULL
used	NULL
for	NULL
wet-to-dry	NULL
determination	NULL
and	NULL
PMN	NULL
counts	NULL
.	NULL

The	NULL
right	NULL
lung	NULL
was	NULL
immediately	NULL
frozen	NULL
in	NULL
liquid	NULL
nitrogen	NULL
and	NULL
stored	NULL
at	NULL
-80°C	NULL
.	NULL

The	NULL
right	NULL
lung	NULL
then	NULL
was	NULL
used	NULL
for	NULL
total	NULL
cellular	NULL
RNA	NULL
extraction	NULL
using	NULL
the	NULL
method	NULL
of	NULL
Chom-eczynski	NULL
and	NULL
Sacchi	NULL
(	NULL
7	NULL
)	NULL
and	NULL
for	NULL
protein	NULL
extraction	NULL
from	NULL
frozen	NULL
sections	NULL
using	NULL
high-salt	NULL
buffer	NULL
for	NULL
use	NULL
in	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
as	NULL
described	NULL
(	NULL
12	NULL
)	NULL
.	NULL

In	NULL
rats	NULL
subjected	NULL
to	NULL
the	NULL
instillation	NULL
of	NULL
IL-6	NULL
,	NULL
median	NULL
sternotomy	NULL
and	NULL
preparation	NULL
of	NULL
the	NULL
trachea	NULL
were	NULL
performed	NULL
,	NULL
and	NULL
the	NULL
left	NULL
INTERLEUKIN-6	NULL
IN	NULL
HEMORRHAGIC	NULL
SHOCK	NULL
pulmonary	NULL
hilus	NULL
was	NULL
isolated	NULL
and	NULL
ligated	NULL
.	NULL

The	NULL
left	NULL
lung	NULL
was	NULL
excised	NULL
and	NULL
removed	NULL
for	NULL
wet-to-dry	NULL
ratio	NULL
.	NULL

The	NULL
right	NULL
lung	NULL
was	NULL
fixed	NULL
by	NULL
inflation	NULL
with	NULL
formaldehyde	NULL
solution	NULL
(	NULL
4	NULL
%	NULL
)	NULL
.	NULL

BAL	NULL
was	NULL
performed	NULL
by	NULL
injecting	NULL
and	NULL
retracting	NULL
3	NULL
ml	NULL
of	NULL
sterile	NULL
saline	NULL
10	NULL
times	NULL
into	NULL
the	NULL
airways	NULL
.	NULL

Cells	NULL
were	NULL
counted	NULL
using	NULL
a	NULL
hemocytom-eter	NULL
.	NULL

A	NULL
differential	NULL
count	NULL
was	NULL
performed	NULL
on	NULL
Wright-stained	NULL
cytospins	NULL
.	NULL

For	NULL
histopathological	NULL
examination	NULL
,	NULL
the	NULL
lungs	NULL
of	NULL
animals	NULL
were	NULL
sectioned	NULL
and	NULL
stained	NULL
for	NULL
myeloperoxidase	NULL
(	NULL
MPO	NULL
;	NULL
see	NULL
Ref	NULL
.	NULL

11	NULL
)	NULL
and	NULL
with	NULL
hematoxylin	NULL
and	NULL
eosin	NULL
(	NULL
H+E	NULL
)	NULL
using	NULL
standard	NULL
procedures	NULL
.	NULL

The	NULL
stained	NULL
slides	NULL
were	NULL
examined	NULL
at	NULL
X400	NULL
magnification	NULL
.	NULL

Ten	NULL
randomly	NULL
chosen	NULL
fields	NULL
of	NULL
each	NULL
lung	NULL
specimen	NULL
were	NULL
blindly	NULL
scored	NULL
for	NULL
number	NULL
of	NULL
intensely	NULL
staining	NULL
MPO-positive	NULL
PMN	NULL
as	NULL
described	NULL
(	NULL
14	NULL
)	NULL
.	NULL

RT-PCR	NULL
amplification	NULL
.	NULL

Total	NULL
RNA	NULL
(	NULL
2.5	NULL
ug	NULL
)	NULL
was	NULL
subjected	NULL
to	NULL
first-strand	NULL
cDNA	NULL
synthesis	NULL
using	NULL
oligo	NULL
(	NULL
dT	NULL
)	NULL
primer	NULL
and	NULL
Moloney	NULL
murine	NULL
leukemia	NULL
virus	NULL
reverse	NULL
transcriptase	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Primers	NULL
for	NULL
amplification	NULL
of	NULL
rat	NULL
IL-6	NULL
cDNA	NULL
were	NULL
based	NULL
on	NULL
rat	NULL
cDNA	NULL
and	NULL
were	NULL
designed	NULL
with	NULL
the	NULL
assistance	NULL
of	NULL
a	NULL
PCR	NULL
primer	NULL
design	NULL
program	NULL
,	NULL
PCR	NULL
Plan	NULL
(	NULL
Intelligenetics	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
5	NULL
'	NULL
primer	NULL
sequence	NULL
was	NULL
ACAGCGATGATGCACTGT-CAG	NULL
.	NULL

The	NULL
3	NULL
'	NULL
primer	NULL
sequence	NULL
was	NULL
ATGGTCTTGGTCCT-TAGCCAC	NULL
.	NULL

The	NULL
primers	NULL
amplified	NULL
a	NULL
product	NULL
of	NULL
~339	NULL
bp	NULL
in	NULL
length	NULL
.	NULL

Restriction	NULL
enzyme	NULL
digestion	NULL
with	NULL
two	NULL
enzymes	NULL
,	NULL
Hinf	NULL
I	NULL
and	NULL
EcoR	NULL
I	NULL
,	NULL
confirmed	NULL
the	NULL
identity	NULL
of	NULL
the	NULL
fragment	NULL
.	NULL

Semiquantitative	NULL
RT-PCR	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
y-	NULL
``	NULL
2P	NULL
end-labeled	NULL
5	NULL
'	NULL
primer	NULL
was	NULL
used	NULL
,	NULL
and	NULL
PCR	NULL
conditions	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
denaturation	NULL
at	NULL
94°C	NULL
for	NULL
1	NULL
min	NULL
;	NULL
annealing	NULL
at	NULL
57°C	NULL
for	NULL
1	NULL
min	NULL
;	NULL
and	NULL
polymerization	NULL
at	NULL
72°C	NULL
for	NULL
2	NULL
min	NULL
in	NULL
a	NULL
Perkin-Elmer	NULL
480	NULL
thermocycler	NULL
.	NULL

The	NULL
optimized	NULL
cycle	NULL
number	NULL
was	NULL
identified	NULL
at	NULL
30	NULL
cycles	NULL
.	NULL

Rat	NULL
peritoneal	NULL
macrophages	NULL
elicited	NULL
with	NULL
thioglycolate	NULL
and	NULL
RAW	NULL
cells	NULL
stimulated	NULL
in	NULL
vitro	NULL
with	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
served	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
for	NULL
rat	NULL
IL-6	NULL
mRNA	NULL
.	NULL

The	NULL
negative	NULL
control	NULL
for	NULL
each	NULL
set	NULL
of	NULL
PCR	NULL
reactions	NULL
contained	NULL
water	NULL
instead	NULL
of	NULL
DNA	NULL
template	NULL
.	NULL

Fifteen	NULL
microliters	NULL
of	NULL
the	NULL
PCR	NULL
reaction	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
10	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

After	NULL
gel	NULL
drying	NULL
and	NULL
exposure	NULL
to	NULL
a	NULL
PhosphorImager	NULL
screen	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
,	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
the	NULL
relative	NULL
radioactivity	NULL
of	NULL
the	NULL
bands	NULL
was	NULL
determined	NULL
by	NULL
volume	NULL
integration	NULL
using	NULL
laser	NULL
scanning	NULL
densitometry	NULL
.	NULL

Each	NULL
gel	NULL
contained	NULL
the	NULL
same	NULL
positive	NULL
control	NULL
,	NULL
which	NULL
permitted	NULL
normalization	NULL
of	NULL
samples	NULL
and	NULL
comparison	NULL
between	NULL
gels	NULL
.	NULL

EMSA	NULL
.	NULL

EMSA	NULL
was	NULL
performed	NULL
using	NULL
whole	NULL
tissue	NULL
extracts	NULL
of	NULL
lung	NULL
sections	NULL
from	NULL
the	NULL
experimental	NULL
groups	NULL
as	NULL
described	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
performed	NULL
using	NULL
20	NULL
ug	NULL
of	NULL
extracted	NULL
protein	NULL
and	NULL
radiolabeled	NULL
DNA-binding	NULL
element	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
Stat3	NULL
was	NULL
assessed	NULL
using	NULL
the	NULL
high-affinity	NULL
serum-inducible	NULL
element	NULL
(	NULL
hSIE	NULL
)	NULL
duplex	NULL
oligonucleotide	NULL
that	NULL
preferentially	NULL
binds	NULL
Stat3	NULL
and	NULL
Statl	NULL
(	NULL
30	NULL
)	NULL
.	NULL

EMSA	NULL
was	NULL
performed	NULL
on	NULL
a	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
as	NULL
described	NULL
(	NULL
6	NULL
)	NULL
.	NULL

The	NULL
level	NULL
of	NULL
Stat3	NULL
activation	NULL
was	NULL
quantitated	NULL
using	NULL
PhosphorImager	NULL
analysis	NULL
of	NULL
gel	NULL
shift	NULL
band	NULL
intensities	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
EMSA	NULL
binding	NULL
reactions	NULL
were	NULL
incubated	NULL
with	NULL
antibodies	NULL
specific	NULL
for	NULL
Statda	NULL
or	NULL
Stat3B	NULL
.	NULL

The	NULL
Stat8a-specific	NULL
antibody	NULL
was	NULL
obtained	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
was	NULL
generated	NULL
in	NULL
rabbits	NULL
against	NULL
the	NULL
COOH-terminal	NULL
20	NULL
of	NULL
21	NULL
amino	NULL
acid	NULL
residues	NULL
of	NULL
murine	NULL
Stat3	NULL
.	NULL

Stat3B-specific	NULL
antibody	NULL
was	NULL
generated	NULL
at	NULL
Charles	NULL
River	NULL
Pharmaservices	NULL
(	NULL
South-bridge	NULL
,	NULL
MA	NULL
)	NULL
by	NULL
immunizing	NULL
chickens	NULL
with	NULL
the	NULL
COOH-terminal	NULL
10	NULL
amino	NULL
acid	NULL
residues	NULL
of	NULL
human	NULL
Stat3B	NULL
conjugated	NULL
to	NULL
thyroglobulin	NULL
(	NULL
12	NULL
)	NULL
.	NULL

In	NULL
situ	NULL
hSIE	NULL
binding	NULL
assay	NULL
.	NULL

Five-micrometer	NULL
sections	NULL
were	NULL
cut	NULL
on	NULL
a	NULL
cryostat	NULL
microtome	NULL
and	NULL
mounted	NULL
on	NULL
positively	NULL
charged	NULL
``	NULL
Superfrost	NULL
``	NULL
slides	NULL
(	NULL
Superfrost	NULL
,	NULL
Fisher	NULL
,	NULL
PA	NULL
)	NULL
.	NULL

Specimens	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
1	NULL
%	NULL
X	NULL
PBS	NULL
and	NULL
incubated	NULL
in	NULL
1x	NULL
PBS	NULL
and	NULL
DNase	NULL
(	NULL
1	NULL
u1/50	NULL
ml	NULL
;	NULL
Ambion	NULL
,	NULL
Austin	NULL
,	NULL
TX	NULL
)	NULL
for	NULL
30	NULL
min	NULL
.	NULL

After	NULL
30	NULL
min	NULL
of	NULL
incubation	NULL
in	NULL
2	NULL
%	NULL
paraformaldehyde	NULL
at	NULL
Downloaded	NULL
from	NULL
www.physiclogy.org/journal/ajplung	NULL
(	NULL
173.236.240.127	NULL
)	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

INTERLEUKIN-6	NULL
IN	NULL
HEMORRHAGIC	NULL
SHOCK	NULL
Compensated	NULL
L613	NULL
4	NULL
hr	NULL
8	NULL
hr	NULL
NL	NULL
Sham	NULL
Shock	NULL
Sham	NULL
Shock	NULL
‘	NULL
Co	NULL
--	NULL
.	NULL

‘	NULL
6	NULL
“	NULL
«	NULL
»	NULL
«	NULL
m	NULL
Decompensated	NULL
F	NULL
tii	NULL
‘	NULL
;	NULL
a=	NULL
IL-6	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Semiquantitative	NULL
RT-PCR	NULL
of	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
-6	NULL
RNA	NULL
from	NULL
lungs	NULL
of	NULL
rats	NULL
subjected	NULL
to	NULL
resuscitated	NULL
hemorrhagic	NULL
shock	NULL
(	NULL
HS	NULL
)	NULL
.	NULL

Reactions	NULL
were	NULL
performed	NULL
using	NULL
total	NULL
RNA	NULL
(	NULL
2.5	NULL
ng	NULL
)	NULL
from	NULL
the	NULL
lungs	NULL
of	NULL
normal	NULL
animals	NULL
or	NULL
animals	NULL
subjected	NULL
to	NULL
compensated	NULL
or	NULL
decompensated	NULL
HS	NULL
and	NULL
killed	NULL
4	NULL
or	NULL
8	NULL
h	NULL
after	NULL
(	NULL
339	NULL
bp	NULL
)	NULL
4	NULL
hr	NULL
8	NULL
hr	NULL
resuscitation	NULL
.	NULL

RT-PCR	NULL
products	NULL
from	NULL
normal	NULL
animals	NULL
(	NULL
NL	NULL
)	NULL
,	NULL
sham	NULL
control	NULL
animals	NULL
(	NULL
Sham	NULL
)	NULL
,	NULL
and	NULL
shock	NULL
Sham	NULL
Shock	NULL
Sham	NULL
Shock	NULL
animals	NULL
(	NULL
Shock	NULL
)	NULL
were	NULL
separated	NULL
on	NULL
polyacrylamide	NULL
gels	NULL
(	NULL
A	NULL
)	NULL
.	NULL

Gels	NULL
were	NULL
dried	NULL
,	NULL
and	NULL
the	NULL
bands	NULL
were	NULL
&	NULL
o	NULL
--	NULL
-	NULL
``	NULL
``	NULL
‘	NULL
QQOO-	NULL
“	NULL
“	NULL
‘	NULL
<	NULL
-	NULL
(	NULL
IL-6	NULL
100	NULL
so	NULL
*	NULL
#	NULL
so	NULL
40	NULL
20	NULL
0	NULL
IL-6	NULL
mRNA	NULL
levels	NULL
(	NULL
Arbitrary	NULL
units	NULL
)	NULL
NL	NULL
_	NULL
4	NULL
hr	NULL
=	NULL
8	NULL
hr	NULL
Compensated	NULL
-	NULL
Decompensated	NULL
room	NULL
temperature	NULL
,	NULL
specimens	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
1	NULL
%	NULL
PBS	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
the	NULL
S-labeled	NULL
hSIE	NULL
duplex	NULL
oligonucleotide	NULL
for	NULL
60	NULL
min	NULL
at	NULL
30°C	NULL
and	NULL
washed	NULL
again	NULL
three	NULL
times	NULL
in	NULL
1X	NULL
PBS	NULL
.	NULL

Specimens	NULL
were	NULL
then	NULL
dehydrated	NULL
and	NULL
submerged	NULL
in	NULL
Kodak	NULL
photographic	NULL
emulsion	NULL
(	NULL
1:1	NULL
dilution	NULL
with	NULL
deionized	NULL
H	NULL
,	NULL
O	NULL
)	NULL
.	NULL

Specimens	NULL
were	NULL
exposed	NULL
to	NULL
Kodak	NULL
film	NULL
for	NULL
5	NULL
days	NULL
,	NULL
developed	NULL
in	NULL
D-19	NULL
(	NULL
Kodak	NULL
)	NULL
for	NULL
20	NULL
min	NULL
,	NULL
and	NULL
visualized	NULL
with	NULL
a	NULL
Nikon	NULL
FXA	NULL
photomicroscope	NULL
.	NULL

Immunohistochemistry	NULL
.	NULL

Frozen	NULL
lung	NULL
sections	NULL
(	NULL
5	NULL
um	NULL
)	NULL
mounted	NULL
on	NULL
positively	NULL
charged	NULL
Superfrost	NULL
slides	NULL
were	NULL
washed	NULL
with	NULL
0.05	NULL
M	NULL
PBS	NULL
and	NULL
PBS	NULL
containing	NULL
1	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
BSA	NULL
)	NULL
each	NULL
three	NULL
times	NULL
,	NULL
incubated	NULL
in	NULL
goat	NULL
serum	NULL
for	NULL
15	NULL
min	NULL
,	NULL
blotted	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
2	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
mouse	NULL
anti-human	NULL
IL-6	NULL
monoclonal	NULL
antibody	NULL
,	NULL
which	NULL
cross-reacts	NULL
with	NULL
rat	NULL
IL-6	NULL
(	NULL
1:50	NULL
dilution	NULL
;	NULL
Endogen	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
or	NULL
with	NULL
a	NULL
nonspecific	NULL
isotype-matched	NULL
control	NULL
.	NULL

Specimens	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
BSA	NULL
,	NULL
incubated	NULL
in	NULL
the	NULL
fluorescent-labeled	NULL
secondary	NULL
indocarbocyanine-conju-gated	NULL
goat	NULL
anti-mouse	NULL
IgG	NULL
antibody	NULL
(	NULL
1:250	NULL
dilution	NULL
;	NULL
Jackson	NULL
ImmunoResearch	NULL
Laboratories	NULL
,	NULL
West	NULL
Grove	NULL
,	NULL
PA	NULL
)	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
BSA	NULL
,	NULL
incubated	NULL
in	NULL
Hertz	NULL
stain	NULL
for	NULL
30	NULL
s	NULL
,	NULL
and	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
BSA	NULL
.	NULL

After	NULL
air	NULL
drying	NULL
,	NULL
specimens	NULL
were	NULL
covered	NULL
with	NULL
coverslips	NULL
and	NULL
Gel-mount	NULL
(	NULL
Biomeda	NULL
)	NULL
and	NULL
inspected	NULL
by	NULL
fluorescent	NULL
microscopy	NULL
(	NULL
Nikon	NULL
FXA	NULL
photomicroscope	NULL
)	NULL
.	NULL

Statistics	NULL
.	NULL

Unless	NULL
otherwise	NULL
indicated	NULL
,	NULL
data	NULL
are	NULL
presented	NULL
as	NULL
means	NULL
+	NULL
SE	NULL
.	NULL

Comparisons	NULL
of	NULL
means	NULL
were	NULL
performed	NULL
using	NULL
ANOVA	NULL
followed	NULL
by	NULL
comparison	NULL
of	NULL
individual	NULL
pairs	NULL
of	NULL
means	NULL
identified	NULL
using	NULL
a	NULL
PhosphorImaging	NULL
screen	NULL
.	NULL

The	NULL
position	NULL
of	NULL
the	NULL
IL-6	NULL
amplified	NULL
product	NULL
(	NULL
339	NULL
bp	NULL
)	NULL
is	NULL
shown	NULL
on	NULL
right	NULL
.	NULL

B	NULL
:	NULL
radioactive	NULL
signal	NULL
within	NULL
the	NULL
339-bp	NULL
amplified	NULL
fragment	NULL
was	NULL
quantitated	NULL
by	NULL
PhosphorImager	NULL
analysis	NULL
,	NULL
and	NULL
the	NULL
mean	NULL
+	NULL
SE	NULL
for	NULL
normal	NULL
animals	NULL
(	NULL
NL	NULL
;	NULL
open	NULL
bar	NULL
)	NULL
,	NULL
sham	NULL
control	NULL
animals	NULL
(	NULL
open	NULL
bars	NULL
)	NULL
,	NULL
and	NULL
shock	NULL
animals	NULL
(	NULL
filled	NULL
bars	NULL
)	NULL
was	NULL
plotted	NULL
.	NULL

Differences	NULL
between	NULL
each	NULL
shock	NULL
and	NULL
sham	NULL
group	NULL
were	NULL
significant	NULL
(	NULL
P	NULL
=	NULL
0.01	NULL
for	NULL
each	NULL
group	NULL
)	NULL
.	NULL

Levels	NULL
of	NULL
amplified	NULL
IL-6	NULL
were	NULL
increased	NULL
43	NULL
%	NULL
at	NULL
4	NULL
h	NULL
after	NULL
resuscitation	NULL
in	NULL
animals	NULL
subjected	NULL
to	NULL
decompensated	NULL
vs.	NULL
compensated	NULL
(	NULL
*P	NULL
=	NULL
0.01	NULL
)	NULL
and	NULL
69	NULL
%	NULL
at	NULL
8	NULL
h	NULL
after	NULL
resuscitation	NULL
in	NULL
animals	NULL
subjected	NULL
to	NULL
decompensated	NULL
vs.	NULL
compensated	NULL
HS	NULL
(	NULL
*P	NULL
=	NULL
0.03	NULL
)	NULL
.	NULL

339	NULL
bp	NULL
)	NULL
using	NULL
the	NULL
Scheffé	NULL
's	NULL
test	NULL
.	NULL

Both	NULL
tests	NULL
are	NULL
contained	NULL
within	NULL
the	NULL
StatView	NULL
4.1	NULL
program	NULL
(	NULL
Abacus	NULL
Concepts	NULL
,	NULL
Berkeley	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

RESULTS	NULL
IL-6	NULL
mRNA	NULL
and	NULL
protein	NULL
are	NULL
increased	NULL
in	NULL
the	NULL
lungs	NULL
of	NULL
rats	NULL
subjected	NULL
to	NULL
HS	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
reported	NULL
that	NULL
rats	NULL
subjected	NULL
to	NULL
our	NULL
HS	NULL
protocol	NULL
demonstrated	NULL
evidence	NULL
of	NULL
acute	NULL
lung	NULL
damage	NULL
with	NULL
increased	NULL
PMN	NULL
infiltration	NULL
and	NULL
elevated	NULL
wet-to-dry	NULL
ratio	NULL
(	NULL
15	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
the	NULL
proinflammatory	NULL
cytokine	NULL
IL-6	NULL
was	NULL
expressed	NULL
locally	NULL
in	NULL
the	NULL
lung	NULL
in	NULL
HS	NULL
where	NULL
it	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
PMN	NULL
recruitment	NULL
and	NULL
lung	NULL
damage	NULL
,	NULL
we	NULL
determined	NULL
IL-6	NULL
mRNA	NULL
levels	NULL
and	NULL
IL-6	NULL
protein	NULL
expression	NULL
in	NULL
the	NULL
lungs	NULL
of	NULL
rats	NULL
subjected	NULL
to	NULL
HS	NULL
.	NULL

Using	NULL
RT-PCR	NULL
with	NULL
end-labeled	NULL
5	NULL
primer	NULL
,	NULL
we	NULL
performed	NULL
semiquantitative	NULL
RT-PCR	NULL
to	NULL
measure	NULL
levels	NULL
of	NULL
IL-6	NULL
mRNA	NULL
in	NULL
the	NULL
lungs	NULL
of	NULL
normal	NULL
rats	NULL
and	NULL
rats	NULL
subjected	NULL
to	NULL
the	NULL
HS	NULL
or	NULL
sham	NULL
protocol	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Lungs	NULL
of	NULL
normal	NULL
rats	NULL
demonstrated	NULL
a	NULL
low	NULL
level	NULL
of	NULL
an	NULL
amplified	NULL
IL-6	NULL
product	NULL
.	NULL

Sham	NULL
animals	NULL
demonstrated	NULL
a	NULL
5.1-	NULL
to	NULL
11.2-fold	NULL
increase	NULL
in	NULL
amplified	NULL
IL-6	NULL
product	NULL
over	NULL
normal	NULL
animals	NULL
(	NULL
P	NULL
<	NULL
0.01	NULL
)	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
amplified	NULL
IL-6	NULL
fragment	NULL
was	NULL
further	NULL
increased	NULL
15.4-	NULL
to	NULL
26.2-fold	NULL
in	NULL
the	NULL
shock	NULL
animals	NULL
over	NULL
normal	NULL
animals	NULL
(	NULL
P	NULL
<	NULL
0.001	NULL
)	NULL
and	NULL
2.4-	NULL
to	NULL
3-fold	NULL
compared	NULL
with	NULL
sham	NULL
control	NULL
animals	NULL
(	NULL
P	NULL
=	NULL
0.01	NULL
)	NULL
for	NULL
each	NULL
group	NULL
Downloaded	NULL
from	NULL
www.physiclogy.org/journal/ajplung	NULL
(	NULL
173.236.240.127	NULL
)	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

L614	NULL
HS	NULL
100x	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Immunofluorescent	NULL
staining	NULL
of	NULL
rat	NULL
lungs	NULL
for	NULL
IL-6	NULL
.	NULL

Frozen	NULL
sections	NULL
of	NULL
a	NULL
representative	NULL
lung	NULL
from	NULL
a	NULL
shock	NULL
animal	NULL
(	NULL
HS	NULL
100	NULL
%	NULL
,	NULL
HS	NULL
400	NULL
%	NULL
,	NULL
and	NULL
HS-IgG	NULL
400	NULL
%	NULL
)	NULL
and	NULL
a	NULL
sham	NULL
animal	NULL
(	NULL
Sham	NULL
400	NULL
%	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
IL-6	NULL
monoclonal	NULL
antibody	NULL
(	NULL
HS	NULL
100	NULL
%	NULL
,	NULL
HS	NULL
400	NULL
%	NULL
,	NULL
and	NULL
Sham	NULL
400	NULL
%	NULL
)	NULL
or	NULL
with	NULL
an	NULL
isotype	NULL
control	NULL
antibody	NULL
(	NULL
HS-IgG	NULL
400	NULL
%	NULL
)	NULL
followed	NULL
by	NULL
incubation	NULL
with	NULL
indocarbocya-nine-conjugated	NULL
secondary	NULL
antibody	NULL
.	NULL

Sections	NULL
were	NULL
visualized	NULL
using	NULL
an	NULL
immunofluorescent	NULL
microscope	NULL
and	NULL
photographed	NULL
at	NULL
the	NULL
indicated	NULL
magnification	NULL
.	NULL

HS-IgG	NULL
400	NULL
%	NULL
examined	NULL
(	NULL
compensated/4	NULL
h	NULL
,	NULL
compensated/8	NULL
h	NULL
,	NULL
decom-pensated/4	NULL
h	NULL
,	NULL
decompensated/8	NULL
h	NULL
)	NULL
.	NULL

Comparison	NULL
of	NULL
compensated	NULL
shock	NULL
groups	NULL
(	NULL
1	NULL
h	NULL
of	NULL
ischemia	NULL
)	NULL
with	NULL
decompensated	NULL
shock	NULL
groups	NULL
(	NULL
2.5	NULL
h	NULL
of	NULL
ischemia	NULL
)	NULL
at	NULL
identical	NULL
time	NULL
points	NULL
of	NULL
death	NULL
after	NULL
resuscitation	NULL
to	NULL
determine	NULL
the	NULL
influence	NULL
of	NULL
the	NULL
duration	NULL
of	NULL
the	NULL
ischemic	NULL
phase	NULL
of	NULL
shock	NULL
on	NULL
IL-6	NULL
mRNA	NULL
levels	NULL
revealed	NULL
a	NULL
43	NULL
%	NULL
increase	NULL
in	NULL
IL-6	NULL
mRNA	NULL
levels	NULL
after	NULL
2.5	NULL
h	NULL
of	NULL
ischemia	NULL
and	NULL
resuscitation	NULL
(	NULL
decompensated	NULL
shock	NULL
)	NULL
and	NULL
death	NULL
after	NULL
4	NULL
h	NULL
versus	NULL
1	NULL
h	NULL
of	NULL
ischemia	NULL
and	NULL
resuscitation	NULL
(	NULL
compensated	NULL
shock	NULL
)	NULL
and	NULL
death	NULL
after	NULL
4	NULL
h	NULL
(	NULL
P	NULL
=	NULL
0.01	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
we	NULL
observed	NULL
a	NULL
69	NULL
%	NULL
increase	NULL
in	NULL
IL-6	NULL
mRNA	NULL
levels	NULL
in	NULL
animals	NULL
subjected	NULL
to	NULL
2.5	NULL
h	NULL
of	NULL
ischemia	NULL
and	NULL
resuscitation	NULL
(	NULL
decompensated	NULL
shock	NULL
)	NULL
and	NULL
death	NULL
after	NULL
8	NULL
h	NULL
versus	NULL
animals	NULL
subjected	NULL
to	NULL
1	NULL
h	NULL
of	NULL
ischemia	NULL
and	NULL
resuscitation	NULL
(	NULL
compensated	NULL
shock	NULL
)	NULL
and	NULL
death	NULL
after	NULL
8	NULL
h	NULL
(	NULL
P	NULL
=	NULL
0.03	NULL
)	NULL
.	NULL

Comparisons	NULL
made	NULL
to	NULL
determine	NULL
the	NULL
influence	NULL
of	NULL
the	NULL
duration	NULL
of	NULL
the	NULL
resuscitation	NULL
phase	NULL
on	NULL
IL-6	NULL
mRNA	NULL
levels	NULL
revealed	NULL
no	NULL
difference	NULL
in	NULL
IL-6	NULL
mRNA	NULL
levels	NULL
4	NULL
h	NULL
after	NULL
resuscitation	NULL
compared	NULL
with	NULL
8	NULL
h	NULL
after	NULL
resuscitation	NULL
in	NULL
either	NULL
group	NULL
.	NULL

To	NULL
establish	NULL
that	NULL
increased	NULL
IL-6	NULL
mRNA	NULL
production	NULL
in	NULL
the	NULL
lungs	NULL
in	NULL
HS	NULL
is	NULL
accompanied	NULL
by	NULL
increased	NULL
IL-6	NULL
protein	NULL
,	NULL
we	NULL
performed	NULL
immunohistochemistry	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

IL-6	NULL
protein	NULL
was	NULL
increased	NULL
in	NULL
shock	NULL
animals	NULL
compared	NULL
with	NULL
sham	NULL
animals	NULL
,	NULL
with	NULL
the	NULL
most	NULL
prominent	NULL
staining	NULL
occurring	NULL
in	NULL
cells	NULL
lining	NULL
the	NULL
bronchioles	NULL
.	NULL

IL-6	NULL
protein	NULL
was	NULL
also	NULL
observed	NULL
in	NULL
alveolar	NULL
macrophages	NULL
,	NULL
but	NULL
staining	NULL
was	NULL
less	NULL
intense	NULL
.	NULL

The	NULL
lungs	NULL
of	NULL
normal	NULL
animals	NULL
did	NULL
not	NULL
demonstrate	NULL
specific	NULL
staining	NULL
for	NULL
IL-6	NULL
protein	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Increased	NULL
expression	NULL
of	NULL
lung	NULL
IL-6	NULL
in	NULL
HS	NULL
requires	NULL
both	NULL
the	NULL
ischemic	NULL
and	NULL
resuscitation	NULL
phases	NULL
and	NULL
occurs	NULL
rapidly	NULL
after	NULL
resuscitation	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
or	NULL
not	NULL
resuscitation	NULL
from	NULL
HS	NULL
was	NULL
required	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
IL-6	NULL
mRNA	NULL
and	NULL
,	NULL
if	NULL
so	NULL
,	NULL
to	NULL
examine	NULL
the	NULL
kinetics	NULL
of	NULL
IL-6	NULL
INTERLEUKIN-6	NULL
IN	NULL
HEMORRHAGIC	NULL
SHOCK	NULL
Sham	NULL
400x	NULL
mRNA	NULL
production	NULL
during	NULL
the	NULL
resuscitation	NULL
phase	NULL
,	NULL
we	NULL
measured	NULL
levels	NULL
of	NULL
IL-6	NULL
mRNA	NULL
at	NULL
the	NULL
end	NULL
of	NULL
the	NULL
ischemic	NULL
phase	NULL
and	NULL
at	NULL
1	NULL
,	NULL
2	NULL
,	NULL
3	NULL
,	NULL
and	NULL
4	NULL
h	NULL
after	NULL
resuscitation	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

IL-6	NULL
mRNA	NULL
was	NULL
not	NULL
increased	NULL
in	NULL
shock	NULL
animals	NULL
at	NULL
the	NULL
end	NULL
of	NULL
the	NULL
ischemic	NULL
phase	NULL
compared	NULL
with	NULL
sham	NULL
animals	NULL
;	NULL
however	NULL
,	NULL
levels	NULL
of	NULL
IL-6	NULL
mRNA	NULL
were	NULL
increased	NULL
over	NULL
sham	NULL
animals	NULL
after	NULL
resuscitation	NULL
at	NULL
all	NULL
time	NULL
points	NULL
examined	NULL
,	NULL
with	NULL
the	NULL
peak	NULL
occurring	NULL
1	NULL
h	NULL
after	NULL
resuscitation	NULL
and	NULL
demonstrating	NULL
a	NULL
5.9-fold	NULL
increase	NULL
over	NULL
sham	NULL
levels	NULL
(	NULL
P	NULL
=	NULL
0.04	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
the	NULL
failure	NULL
of	NULL
ischemia	NULL
alone	NULL
to	NULL
induce	NULL
IL-6	NULL
production	NULL
above	NULL
sham	NULL
levels	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
lungs	NULL
of	NULL
animals	NULL
for	NULL
IL-6	NULL
mRNA	NULL
production	NULL
in	NULL
two	NULL
additional	NULL
HS	NULL
protocols	NULL
in	NULL
which	NULL
animals	NULL
were	NULL
subjected	NULL
to	NULL
unresuscitated	NULL
compensated	NULL
and	NULL
unresuscitated	NULL
irreversible	NULL
HS	NULL
.	NULL

With	NULL
semiquantitative	NULL
IL-6	NULL
RT-PCR	NULL
,	NULL
there	NULL
was	NULL
no	NULL
difference	NULL
in	NULL
IL-6	NULL
mRNA	NULL
levels	NULL
between	NULL
shock	NULL
and	NULL
sham	NULL
animals	NULL
regardless	NULL
of	NULL
the	NULL
severity	NULL
of	NULL
shock	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

Even	NULL
in	NULL
animals	NULL
subjected	NULL
to	NULL
irreversible	NULL
HS	NULL
,	NULL
an	NULL
ischemic	NULL
injury	NULL
that	NULL
would	NULL
have	NULL
had	NULL
a	NULL
100	NULL
%	NULL
lethality	NULL
,	NULL
levels	NULL
of	NULL
IL-6	NULL
mRNA	NULL
were	NULL
not	NULL
elevated	NULL
over	NULL
levels	NULL
found	NULL
in	NULL
sham	NULL
animals	NULL
.	NULL

Stat3	NULL
activation	NULL
in	NULL
HS	NULL
requires	NULL
the	NULL
resuscitation	NULL
phase	NULL
and	NULL
exhibits	NULL
similar	NULL
kinetics	NULL
to	NULL
IL-6	NULL
induction	NULL
.	NULL

IL-6	NULL
signals	NULL
through	NULL
activation	NULL
of	NULL
Stat3	NULL
.	NULL

We	NULL
previously	NULL
demonstrated	NULL
activation	NULL
of	NULL
STAT	NULL
proteins	NULL
,	NULL
particularly	NULL
Stat3	NULL
,	NULL
in	NULL
the	NULL
lungs	NULL
of	NULL
animals	NULL
subjected	NULL
to	NULL
resuscitated	NULL
HS	NULL
(	NULL
13	NULL
)	NULL
.	NULL

It	NULL
is	NULL
not	NULL
known	NULL
if	NULL
the	NULL
resuscitation	NULL
phase	NULL
is	NULL
necessary	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
Stat3	NULL
or	NULL
the	NULL
time	NULL
course	NULL
of	NULL
the	NULL
activation	NULL
of	NULL
Stat3	NULL
after	NULL
resuscitation	NULL
.	NULL

Protein	NULL
extracts	NULL
of	NULL
lungs	NULL
from	NULL
shock	NULL
animals	NULL
killed	NULL
at	NULL
the	NULL
end	NULL
of	NULL
the	NULL
2.5-h	NULL
ischemic	NULL
phase	NULL
(	NULL
decompensated	NULL
shock	NULL
)	NULL
did	NULL
not	NULL
demonstrate	NULL
increased	NULL
Stat3	NULL
activity	NULL
compared	NULL
with	NULL
sham	NULL
animals	NULL
with	NULL
the	NULL
use	NULL
of	NULL
EMSA	NULL
gel	NULL
shift	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
we	NULL
found	NULL
that	NULL
Stat3	NULL
activity	NULL
Downloaded	NULL
from	NULL
www.physiclogy.org/journal/ajplung	NULL
(	NULL
173.236.240.127	NULL
)	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

0	NULL
hr	NULL
1	NULL
hr	NULL
2	NULL
hr	NULL
Sham	NULL
Shock	NULL
Sham	NULL
Shock	NULL
Sham	NULL
Shock	NULL
i	NULL
``	NULL
tt	NULL
.	NULL

us	NULL
'	NULL
e	NULL
us	NULL
s	NULL
un	NULL
-e	NULL
8	NULL
o	NULL
8	NULL
.	NULL

_	NULL
-	NULL
te	NULL
da	NULL
(	NULL
339	NULL
bp	NULL
)	NULL
3	NULL
hr	NULL
4	NULL
hr	NULL
Sham	NULL
Shock	NULL
Sham	NULL
Shock	NULL
we	NULL
-	NULL
an	NULL
-	NULL
am	NULL
&	NULL
&	NULL
d	NULL
&	NULL
a-	NULL
~	NULL
t	NULL
a	NULL
&	NULL
--	NULL
4s	NULL
||	NULL
-G	NULL
(	NULL
339	NULL
bp	NULL
)	NULL
IL-6	NULL
mRNA	NULL
levels	NULL
(	NULL
Arbitrary	NULL
units	NULL
)	NULL
25	NULL
,	NULL
20	NULL
4	NULL
15	NULL
IL-6	NULL
mRNA	NULL
levels	NULL
(	NULL
Arbitrary	NULL
units	NULL
)	NULL
C	NULL
|	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Semiquantitative	NULL
RT-PCR	NULL
of	NULL
IL-6	NULL
mRNA	NULL
from	NULL
lungs	NULL
of	NULL
rats	NULL
subjected	NULL
to	NULL
unresuscitated	NULL
and	NULL
resuscitated	NULL
HS	NULL
.	NULL

RT-PCR	NULL
reactions	NULL
were	NULL
performed	NULL
using	NULL
total	NULL
RNA	NULL
(	NULL
2.5	NULL
pg	NULL
)	NULL
from	NULL
the	NULL
lungs	NULL
of	NULL
animals	NULL
subjected	NULL
to	NULL
the	NULL
decompensated	NULL
(	NULL
2.5	NULL
h	NULL
of	NULL
ischemia	NULL
)	NULL
HS	NULL
or	NULL
sham	NULL
protocol	NULL
without	NULL
resuscitation	NULL
(	NULL
0	NULL
h	NULL
)	NULL
or	NULL
1	NULL
(	NULL
R1	NULL
)	NULL
,	NULL
2	NULL
(	NULL
R2	NULL
)	NULL
,	NULL
3	NULL
(	NULL
R3	NULL
)	NULL
,	NULL
or	NULL
4	NULL
(	NULL
R4	NULL
)	NULL
h	NULL
after	NULL
resuscitation	NULL
.	NULL

Reaction	NULL
products	NULL
were	NULL
separated	NULL
on	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

Gels	NULL
were	NULL
dried	NULL
and	NULL
exposed	NULL
to	NULL
a	NULL
PhosphorImaging	NULL
screen	NULL
and	NULL
developed	NULL
using	NULL
a	NULL
PhosphorImager	NULL
(	NULL
A	NULL
)	NULL
.	NULL

The	NULL
location	NULL
of	NULL
the	NULL
amplified	NULL
IL-6	NULL
fragment	NULL
(	NULL
339	NULL
bp	NULL
)	NULL
is	NULL
indicated	NULL
on	NULL
right	NULL
.	NULL

In	NULL
B	NULL
,	NULL
the	NULL
radioactive	NULL
signal	NULL
within	NULL
the	NULL
amplified	NULL
fragment	NULL
was	NULL
quantitated	NULL
using	NULL
scanner	NULL
laser	NULL
densitometry	NULL
and	NULL
ImageQuant	NULL
software	NULL
,	NULL
and	NULL
the	NULL
mean	NULL
+	NULL
SE	NULL
of	NULL
the	NULL
sham	NULL
groups	NULL
(	NULL
open	NULL
bars	NULL
)	NULL
and	NULL
shock	NULL
groups	NULL
(	NULL
filled	NULL
bars	NULL
)	NULL
was	NULL
plotted	NULL
.	NULL

The	NULL
differences	NULL
between	NULL
each	NULL
resuscitated	NULL
shock	NULL
and	NULL
sham	NULL
group	NULL
were	NULL
significant	NULL
(	NULL
P	NULL
=	NULL
0.01	NULL
for	NULL
each	NULL
comparison	NULL
)	NULL
.	NULL

There	NULL
was	NULL
no	NULL
difference	NULL
between	NULL
the	NULL
mean	NULL
of	NULL
the	NULL
shock	NULL
and	NULL
sham	NULL
groups	NULL
without	NULL
resuscitation	NULL
(	NULL
0	NULL
h	NULL
;	NULL
P	NULL
=	NULL
0.6	NULL
)	NULL
.	NULL

The	NULL
mean	NULL
of	NULL
the	NULL
shock	NULL
groups	NULL
at	NULL
1	NULL
,	NULL
2	NULL
,	NULL
3	NULL
,	NULL
and	NULL
4	NULL
h	NULL
was	NULL
significantly	NULL
increased	NULL
over	NULL
the	NULL
unresuscitated	NULL
(	NULL
0	NULL
h	NULL
)	NULL
group	NULL
(	NULL
P	NULL
=	NULL
<	NULL
0.04	NULL
)	NULL
.	NULL

In	NULL
C	NULL
,	NULL
RT-PCR	NULL
reactions	NULL
were	NULL
performed	NULL
using	NULL
total	NULL
RNA	NULL
(	NULL
2.5	NULL
ug	NULL
)	NULL
from	NULL
the	NULL
lungs	NULL
of	NULL
animals	NULL
subjected	NULL
to	NULL
compensated	NULL
(	NULL
C	NULL
;	NULL
1	NULL
h	NULL
of	NULL
ischemia	NULL
)	NULL
or	NULL
irreversible	NULL
(	NULL
I	NULL
;	NULL
3.5	NULL
h	NULL
of	NULL
ischemia	NULL
)	NULL
shock	NULL
protocol	NULL
without	NULL
resuscitation	NULL
(	NULL
filled	NULL
bars	NULL
)	NULL
or	NULL
to	NULL
the	NULL
corresponding	NULL
sham	NULL
procedure	NULL
(	NULL
open	NULL
bars	NULL
)	NULL
.	NULL

Reaction	NULL
products	NULL
were	NULL
separated	NULL
on	NULL
polyacrylamide	NULL
gels	NULL
and	NULL
quantitated	NULL
as	NULL
above	NULL
.	NULL

Values	NULL
shown	NULL
are	NULL
means	NULL
+	NULL
SE	NULL
of	NULL
each	NULL
group	NULL
(	NULL
r	NULL
=	NULL
4	NULL
)	NULL
.	NULL

There	NULL
were	NULL
no	NULL
differences	NULL
between	NULL
shock	NULL
and	NULL
sham	NULL
groups	NULL
within	NULL
either	NULL
set	NULL
(	NULL
P	NULL
=	NULL
0.7	NULL
)	NULL
.	NULL

Downloaded	NULL
from	NULL
www.physiclogy.org/journal/ajplung	NULL
(	NULL
173.236.240.127	NULL
)	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

L616	NULL
INTERLEUKIN-6	NULL
IN	NULL
HEMORRHAGIC	NULL
SHOCK	NULL
Q	NULL
hr	NULL
1	NULL
hr	NULL
2	NULL
hr	NULL
3	NULL
hr	NULL
4	NULL
hr	NULL
14	NULL
Sham	NULL
Sham	NULL
Sham	NULL
Sham	NULL
HS	NULL
Sham	NULL
HS	NULL
c	NULL
~	NULL
12	NULL
o	NULL
2	NULL
¥	NULL
ﬁ	NULL
ZE	NULL
>	NULL
10	NULL
so	NULL
typ	NULL
bo	NULL
wd	NULL
bt	NULL
tp	NULL
SIF	NULL
A	NULL
od	NULL
B	NULL
v*	NULL
#	NULL
|	NULL
”	NULL
55m	NULL
1l'wzsnﬂa	NULL
335	NULL
,	NULL
8	NULL
``	NULL
I	NULL
hd	NULL
ba	NULL
dh	NULL
&	NULL
ds	NULL
dik	NULL
ha	NULL
I	NULL
bi	NULL
«	NULL
*	NULL
SF	NULL
C	NULL
8	NULL
©	NULL
6	NULL
o	NULL
4	NULL
a	NULL
£	NULL
B	NULL
I	NULL
<	NULL
'	NULL
60	NULL
2	NULL
0	NULL
4	NULL
5g	NULL
``	NULL
f	NULL
|	NULL
8	NULL
5	NULL
a	NULL
D	NULL
.	NULL

§	NULL
=	NULL
anti-Stat3	NULL
©	NULL
g	NULL
30	NULL
o	NULL
5	NULL
a	NULL
B	NULL
B	NULL
5	NULL
<	NULL
»	NULL
10	NULL
Supershifted	NULL
complex	NULL
0	NULL
ROQ	NULL
R	NULL
1	NULL
R2	NULL
R	NULL
3	NULL
R4	NULL
SIF	NULL
A	NULL
=t	NULL
»	NULL
«	NULL
m	NULL
Statdy	NULL
SIF	NULL
B	NULL
=m	NULL
»	NULL
SIF	NULL
C	NULL
=m	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Stat3	NULL
activation	NULL
in	NULL
the	NULL
lung	NULL
after	NULL
unresuscitated	NULL
and	NULL
resuscitated	NULL
HS	NULL
.	NULL

In	NULL
A	NULL
,	NULL
protein	NULL
extracts	NULL
were	NULL
obtained	NULL
from	NULL
frozen	NULL
sections	NULL
of	NULL
lungs	NULL
from	NULL
animals	NULL
subjected	NULL
to	NULL
decompensated	NULL
(	NULL
2.5	NULL
h	NULL
of	NULL
ischemia	NULL
)	NULL
HS	NULL
without	NULL
resuscitation	NULL
(	NULL
RO	NULL
)	NULL
or	NULL
decompensated	NULL
HS	NULL
followed	NULL
by	NULL
1	NULL
(	NULL
R1	NULL
)	NULL
,	NULL
2	NULL
(	NULL
R2	NULL
)	NULL
,	NULL
3	NULL
(	NULL
R3	NULL
)	NULL
,	NULL
or	NULL
4	NULL
(	NULL
R4	NULL
)	NULL
h	NULL
of	NULL
resuscitation	NULL
or	NULL
to	NULL
the	NULL
corresponding	NULL
sham	NULL
procedure	NULL
.	NULL

Extracts	NULL
(	NULL
20	NULL
pug	NULL
)	NULL
were	NULL
used	NULL
in	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSA	NULL
)	NULL
with	NULL
the	NULL
radiolabeled	NULL
high-affinity	NULL
serum-inducible	NULL
element	NULL
(	NULL
hSIE	NULL
)	NULL
duplex	NULL
oligonucleotide	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
serum-inducible	NULL
factor	NULL
(	NULL
SIF	NULL
)	NULL
-A	NULL
(	NULL
Stat3	NULL
homodimer	NULL
)	NULL
,	NULL
SIF-B	NULL
(	NULL
Statl/Stat3	NULL
heterodimer	NULL
)	NULL
,	NULL
and	NULL
SIF-C	NULL
(	NULL
Statl	NULL
homodimer	NULL
)	NULL
complexes	NULL
are	NULL
indicated	NULL
on	NULL
right	NULL
.	NULL

In	NULL
B	NULL
,	NULL
the	NULL
SIF-A	NULL
band	NULL
was	NULL
quantitated	NULL
by	NULL
PhosphorImager	NULL
analysis	NULL
,	NULL
and	NULL
the	NULL
mean	NULL
+	NULL
SE	NULL
for	NULL
shock	NULL
animals	NULL
(	NULL
filled	NULL
bars	NULL
)	NULL
and	NULL
sham	NULL
control	NULL
animals	NULL
(	NULL
open	NULL
bars	NULL
)	NULL
was	NULL
plotted	NULL
.	NULL

Differences	NULL
between	NULL
each	NULL
resuscitated	NULL
shock	NULL
and	NULL
sham	NULL
group	NULL
were	NULL
significant	NULL
(	NULL
P	NULL
<	NULL
0.01	NULL
for	NULL
each	NULL
comparison	NULL
)	NULL
.	NULL

There	NULL
was	NULL
no	NULL
difference	NULL
between	NULL
the	NULL
mean	NULL
of	NULL
the	NULL
shock	NULL
and	NULL
sham	NULL
groups	NULL
without	NULL
resuscitation	NULL
(	NULL
0	NULL
h	NULL
;	NULL
P	NULL
=	NULL
0.4	NULL
)	NULL
.	NULL

The	NULL
mean	NULL
of	NULL
the	NULL
shock	NULL
groups	NULL
at	NULL
1	NULL
,	NULL
2	NULL
,	NULL
3	NULL
,	NULL
and	NULL
4	NULL
h	NULL
was	NULL
significantly	NULL
increased	NULL
over	NULL
the	NULL
unresuscitated	NULL
(	NULL
0	NULL
h	NULL
)	NULL
group	NULL
(	NULL
P	NULL
<	NULL
0.02	NULL
)	NULL
.	NULL

In	NULL
C	NULL
,	NULL
EMSA	NULL
was	NULL
performed	NULL
using	NULL
extracts	NULL
from	NULL
the	NULL
lungs	NULL
of	NULL
rats	NULL
subjected	NULL
to	NULL
compensated	NULL
(	NULL
C	NULL
;	NULL
1	NULL
h	NULL
of	NULL
ischemia	NULL
)	NULL
or	NULL
irreversible	NULL
(	NULL
I	NULL
;	NULL
3.5	NULL
h	NULL
of	NULL
ischemia	NULL
)	NULL
HS	NULL
(	NULL
filled	NULL
bars	NULL
)	NULL
without	NULL
resuscitation	NULL
or	NULL
to	NULL
the	NULL
corresponding	NULL
sham	NULL
procedure	NULL
(	NULL
open	NULL
bars	NULL
)	NULL
.	NULL

The	NULL
SIF-A	NULL
band	NULL
was	NULL
quantitated	NULL
by	NULL
PhosphorImager	NULL
analysis	NULL
as	NULL
above	NULL
,	NULL
and	NULL
the	NULL
mean	NULL
+	NULL
SE	NULL
for	NULL
each	NULL
group	NULL
was	NULL
plotted	NULL
.	NULL

There	NULL
was	NULL
no	NULL
difference	NULL
between	NULL
the	NULL
mean	NULL
of	NULL
the	NULL
shock	NULL
and	NULL
sham	NULL
groups	NULL
in	NULL
any	NULL
of	NULL
these	NULL
unresuscitated	NULL
animals	NULL
(	NULL
P	NULL
=	NULL
0.5	NULL
,	NULL
0.7	NULL
,	NULL
and	NULL
0.8	NULL
)	NULL
.	NULL

In	NULL
D	NULL
,	NULL
extracts	NULL
of	NULL
lungs	NULL
from	NULL
a	NULL
representative	NULL
shock	NULL
animal	NULL
were	NULL
incubated	NULL
with	NULL
antibodies	NULL
specific	NULL
for	NULL
Stat3	NULL
«	NULL
or	NULL
Stat3	NULL
$	NULL
or	NULL
with	NULL
both	NULL
antibodies	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
SIF-A	NULL
,	NULL
-B	NULL
,	NULL
and	NULL
-C	NULL
complexes	NULL
,	NULL
the	NULL
supershifted	NULL
complex	NULL
,	NULL
and	NULL
the	NULL
residual	NULL
SIF-A	NULL
complex	NULL
after	NULL
supershift	NULL
of	NULL
Stat3	NULL
«	NULL
and	NULL
Stat38B	NULL
(	NULL
Stat3y	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

was	NULL
increased	NULL
after	NULL
resuscitation	NULL
at	NULL
all	NULL
time	NULL
points	NULL
examined	NULL
,	NULL
peaking	NULL
1	NULL
h	NULL
after	NULL
resuscitation	NULL
with	NULL
a	NULL
level	NULL
of	NULL
activity	NULL
9.2-fold	NULL
greater	NULL
than	NULL
sham	NULL
controls	NULL
(	NULL
P	NULL
=	NULL
0.02	NULL
)	NULL
.	NULL

Similar	NULL
to	NULL
IL-6	NULL
mRNA	NULL
levels	NULL
,	NULL
there	NULL
was	NULL
no	NULL
difference	NULL
in	NULL
Stat3	NULL
activity	NULL
between	NULL
shock	NULL
and	NULL
sham	NULL
animals	NULL
in	NULL
unresuscitated	NULL
compensated	NULL
(	NULL
1	NULL
h	NULL
of	NULL
ischemia	NULL
)	NULL
and	NULL
irreversible	NULL
(	NULL
8.5	NULL
h	NULL
of	NULL
ischemia	NULL
)	NULL
HS	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

Three	NULL
distinct	NULL
isoforms	NULL
of	NULL
Stat3	NULL
have	NULL
been	NULL
identified	NULL
,	NULL
Stat3a	NULL
«	NULL
,	NULL
Stat3B	NULL
,	NULL
and	NULL
Stat3y	NULL
.	NULL

Stat3	NULL
«	NULL
(	NULL
92	NULL
kDa	NULL
)	NULL
is	NULL
the	NULL
predominant	NULL
isoform	NULL
expressed	NULL
in	NULL
most	NULL
cells	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Stat3B	NULL
(	NULL
83	NULL
kDa	NULL
)	NULL
arises	NULL
from	NULL
alternative	NULL
splicing	NULL
of	NULL
the	NULL
Stat8	NULL
gene	NULL
transcript	NULL
,	NULL
resulting	NULL
in	NULL
a	NULL
50-nucleotide	NULL
deletion	NULL
at	NULL
the	NULL
3	NULL
'	NULL
end	NULL
of	NULL
the	NULL
open	NULL
reading	NULL
frame	NULL
of	NULL
Stata	NULL
(	NULL
6	NULL
,	NULL
27	NULL
)	NULL
.	NULL

The	NULL
third	NULL
isoform	NULL
,	NULL
Stat3y	NULL
,	NULL
is	NULL
a	NULL
72-kDa	NULL
protein	NULL
identified	NULL
in	NULL
granulocyte	NULL
colony-stimulating	NULL
factor-activated	NULL
mature	NULL
neutrophils	NULL
and	NULL
is	NULL
derived	NULL
from	NULL
Stat3	NULL
«	NULL
by	NULL
posttranslational	NULL
modification	NULL
involving	NULL
proteolysis	NULL
(	NULL
A.	NULL
Chakraborty	NULL
and	NULL
D.	NULL
J.	NULL
Tweardy	NULL
,	NULL
unpublished	NULL
observa-tion	NULL
)	NULL
.	NULL

Stat3	NULL
«	NULL
and	NULL
Stat3B	NULL
each	NULL
are	NULL
supershifted	NULL
by	NULL
specific	NULL
antibodies	NULL
;	NULL
no	NULL
antibody	NULL
is	NULL
available	NULL
that	NULL
can	NULL
supershift	NULL
only	NULL
Stat3y	NULL
.	NULL

We	NULL
added	NULL
antibody	NULL
specific	NULL
to	NULL
either	NULL
Stat3a	NULL
«	NULL
or	NULL
Stat3B	NULL
or	NULL
both	NULL
antibodies	NULL
to	NULL
binding	NULL
reactions	NULL
containing	NULL
radiolabeled	NULL
hSIE	NULL
duplex	NULL
oligonucleotide	NULL
to	NULL
determine	NULL
which	NULL
of	NULL
these	NULL
Stat3	NULL
isoforms	NULL
are	NULL
activated	NULL
in	NULL
the	NULL
lungs	NULL
of	NULL
shock	NULL
animals	NULL
.	NULL

Addition	NULL
of	NULL
either	NULL
Stat3a	NULL
«	NULL
-specific	NULL
antibody	NULL
or	NULL
Stat3B-specific	NULL
antibody	NULL
each	NULL
supershifted	NULL
a	NULL
portion	NULL
of	NULL
the	NULL
serum-inducible	NULL
factor	NULL
(	NULL
SIF	NULL
)	NULL
-A	NULL
complex	NULL
.	NULL

Addition	NULL
of	NULL
both	NULL
antibodies	NULL
together	NULL
supershifted	NULL
a	NULL
greater	NULL
portion	NULL
than	NULL
either	NULL
alone	NULL
but	NULL
did	NULL
not	NULL
supershift	NULL
all	NULL
of	NULL
the	NULL
SIF-A	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

4D	NULL
)	NULL
.	NULL

The	NULL
remaining	NULL
SIF-A	NULL
complex	NULL
has	NULL
the	NULL
mobility	NULL
of	NULL
Stat3y	NULL
(	NULL
Fig	NULL
.	NULL

4D	NULL
)	NULL
.	NULL

Thus	NULL
all	NULL
isoforms	NULL
of	NULL
Stat3	NULL
were	NULL
activated	NULL
in	NULL
the	NULL
lung	NULL
in	NULL
HS	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
Stat3y	NULL
corresponds	NULL
to	NULL
our	NULL
finding	NULL
of	NULL
PMN	NULL
recruitment	NULL
into	NULL
the	NULL
lung	NULL
after	NULL
resuscitated	NULL
HS	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
cellular	NULL
site	NULL
of	NULL
Stat3	NULL
activation	NULL
in	NULL
the	NULL
lungs	NULL
after	NULL
HS	NULL
,	NULL
we	NULL
performed	NULL
an	NULL
in	NULL
situ	NULL
binding	NULL
assay	NULL
using	NULL
frozen	NULL
lung	NULL
sections	NULL
and	NULL
*5S-radiolabeled	NULL
Downloaded	NULL
from	NULL
www.physiclogy.org/journal/ajplung	NULL
(	NULL
173.236.240.127	NULL
)	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

INTERLEUKIN-6	NULL
IN	NULL
HEMORRHAGIC	NULL
SHOCK	NULL
sa	NULL
arie	NULL
s	NULL
UT	NULL
,	NULL
Arpels	NULL
.	NULL

e	NULL
<	NULL
A	NULL
“	NULL
9,024	NULL
ia	NULL
vig	NULL
,	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

In	NULL
situ	NULL
hSIE	NULL
binding	NULL
assay	NULL
of	NULL
shock	NULL
and	NULL
sham	NULL
lung	NULL
.	NULL

Frozen	NULL
sections	NULL
of	NULL
uninflated	NULL
lung	NULL
from	NULL
a	NULL
representative	NULL
decompensated	NULL
shock	NULL
animal	NULL
(	NULL
2.5	NULL
h	NULL
ischemia	NULL
followed	NULL
by	NULL
resuscitation	NULL
and	NULL
death	NULL
at	NULL
4	NULL
h	NULL
;	NULL
B	NULL
)	NULL
or	NULL
the	NULL
corresponding	NULL
sham	NULL
animal	NULL
(	NULL
A	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
*58-labeled	NULL
hSIE	NULL
duplex	NULL
oligonucleotide	NULL
and	NULL
developed	NULL
as	NULL
described	NULL
in	NULL
MATERIALS	NULL
AND	NULL
METHODS	NULL
.	NULL

Photographs	NULL
of	NULL
bright-field	NULL
views	NULL
(	NULL
magnification	NULL
X400	NULL
)	NULL
are	NULL
shown	NULL
.	NULL

Prominent	NULL
binding	NULL
of	NULL
radiolabeled	NULL
hSIE	NULL
is	NULL
indicated	NULL
by	NULL
arrows	NULL
in	NULL
B.	NULL
hSIFE	NULL
duplex	NULL
oligonucleotide	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Examination	NULL
of	NULL
the	NULL
shock	NULL
lung	NULL
specimens	NULL
after	NULL
incubation	NULL
with	NULL
the	NULL
hSIE	NULL
probe	NULL
was	NULL
most	NULL
notable	NULL
for	NULL
binding	NULL
of	NULL
labeled	NULL
probe	NULL
within	NULL
alveolar	NULL
cells	NULL
.	NULL

Specimens	NULL
from	NULL
sham	NULL
animals	NULL
did	NULL
not	NULL
demonstrate	NULL
binding	NULL
of	NULL
the	NULL
probe	NULL
.	NULL

Intratracheal	NULL
instillation	NULL
of	NULL
IL-6	NULL
into	NULL
the	NULL
lungs	NULL
resulted	NULL
in	NULL
PMN	NULL
infiltration	NULL
and	NULL
lung	NULL
damage	NULL
.	NULL

IL-6	NULL
has	NULL
been	NULL
recently	NULL
shown	NULL
to	NULL
cause	NULL
tissue	NULL
accumulation	NULL
of	NULL
PMN	NULL
through	NULL
the	NULL
induction	NULL
of	NULL
chemokines	NULL
such	NULL
as	NULL
IL-8	NULL
(	NULL
26	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
or	NULL
not	NULL
IL-6	NULL
protein	NULL
alone	NULL
is	NULL
sufficient	NULL
to	NULL
cause	NULL
PMN	NULL
accumulation	NULL
in	NULL
the	NULL
lungs	NULL
of	NULL
rats	NULL
,	NULL
we	NULL
instilled	NULL
IL-6	NULL
protein	NULL
(	NULL
300	NULL
ng	NULL
)	NULL
by	NULL
syringe	NULL
injection	NULL
through	NULL
an	NULL
intratracheal	NULL
tube	NULL
.	NULL

BAL	NULL
was	NULL
performed	NULL
on	NULL
IL-6-treated	NULL
animals	NULL
,	NULL
and	NULL
BAL	NULL
cellularity	NULL
was	NULL
determined	NULL
at	NULL
2	NULL
,	NULL
4	NULL
,	NULL
8	NULL
,	NULL
12	NULL
,	NULL
24	NULL
,	NULL
and	NULL
48	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

The	NULL
BAL	NULL
cellularity	NULL
was	NULL
increased	NULL
at	NULL
all	NULL
time	NULL
points	NULL
examined	NULL
and	NULL
peaked	NULL
at	NULL
4	NULL
h	NULL
,	NULL
achieving	NULL
a	NULL
5.6-fold	NULL
increase	NULL
compared	NULL
with	NULL
control	NULL
saline-treated	NULL
animals	NULL
(	NULL
P	NULL
=	NULL
0.03	NULL
)	NULL
.	NULL

Examination	NULL
of	NULL
Wright-Giemsa	NULL
stain	NULL
of	NULL
BAL	NULL
cells	NULL
at	NULL
4	NULL
h	NULL
after	NULL
IL-6	NULL
instillation	NULL
revealed	NULL
that	NULL
45	NULL
+	NULL
8	NULL
%	NULL
of	NULL
the	NULL
isolated	NULL
cells	NULL
were	NULL
PMN	NULL
.	NULL

To	NULL
examine	NULL
IL-6-induced	NULL
PMN	NULL
recruitment	NULL
into	NULL
the	NULL
lung	NULL
in	NULL
greater	NULL
detail	NULL
,	NULL
lungs	NULL
of	NULL
rats	NULL
were	NULL
sectioned	NULL
and	NULL
stained	NULL
for	NULL
MPO	NULL
and	NULL
with	NULL
H+E	NULL
.	NULL

Examination	NULL
of	NULL
MPO-stained	NULL
sections	NULL
of	NULL
lungs	NULL
of	NULL
rats	NULL
that	NULL
received	NULL
IL-6	NULL
revealed	NULL
many	NULL
MPO-positive	NULL
cells	NULL
compared	NULL
with	NULL
animals	NULL
receiving	NULL
the	NULL
saline	NULL
control	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
A	NULL
and	NULL
C	NULL
)	NULL
.	NULL

To	NULL
quantitatively	NULL
assess	NULL
the	NULL
increase	NULL
in	NULL
PMN	NULL
recruitment	NULL
into	NULL
the	NULL
interstitium	NULL
and	NULL
alveoli	NULL
of	NULL
lungs	NULL
of	NULL
animals	NULL
receiving	NULL
IL-6	NULL
or	NULL
saline	NULL
control	NULL
,	NULL
MPO-stained	NULL
slides	NULL
from	NULL
lung	NULL
cross	NULL
sections	NULL
were	NULL
examined	NULL
at	NULL
X400	NULL
magnification	NULL
at	NULL
2	NULL
,	NULL
4	NULL
,	NULL
8	NULL
,	NULL
12	NULL
,	NULL
24	NULL
,	NULL
and	NULL
48	NULL
h	NULL
after	NULL
IL-6	NULL
instillation	NULL
.	NULL

Ten	NULL
random	NULL
fields	NULL
of	NULL
each	NULL
lung	NULL
specimen	NULL
were	NULL
scored	NULL
blindly	NULL
for	NULL
number	NULL
of	NULL
intensely	NULL
staining	NULL
MPO-positive	NULL
PMN	NULL
.	NULL

The	NULL
scores	NULL
were	NULL
pooled	NULL
,	NULL
and	NULL
the	NULL
means	NULL
+	NULL
SE	NULL
were	NULL
calculated	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
.	NULL

Lungs	NULL
of	NULL
IL-6-treated	NULL
animals	NULL
demonstrated	NULL
an	NULL
increase	NULL
in	NULL
MPO-positive	NULL
PMN	NULL
in	NULL
both	NULL
the	NULL
interstitium	NULL
and	NULL
alveoli	NULL
at	NULL
4	NULL
,	NULL
8	NULL
,	NULL
12	NULL
,	NULL
24	NULL
,	NULL
and	NULL
48	NULL
h	NULL
compared	NULL
with	NULL
saline-treated	NULL
animals	NULL
,	NULL
with	NULL
the	NULL
peak	NULL
of	NULL
PMN	NULL
accumulation	NULL
occurring	NULL
from	NULL
4	NULL
to	NULL
12	NULL
h.	NULL
To	NULL
determine	NULL
the	NULL
minimum	NULL
amount	NULL
of	NULL
IL-6	NULL
necessary	NULL
to	NULL
result	NULL
in	NULL
lung	NULL
PMN	NULL
accumulation	NULL
,	NULL
animals	NULL
were	NULL
examined	NULL
4	NULL
h	NULL
after	NULL
receiving	NULL
10	NULL
,	NULL
30	NULL
,	NULL
100	NULL
,	NULL
and	NULL
300	NULL
ng	NULL
of	NULL
IL-6	NULL
by	NULL
tracheal	NULL
instillation	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

There	NULL
was	NULL
a	NULL
linear	NULL
increase	NULL
in	NULL
MPO-positive	NULL
cells	NULL
(	NULL
r	NULL
=	NULL
0.74	NULL
;	NULL
P	NULL
<	NULL
0.03	NULL
)	NULL
with	NULL
increasing	NULL
doses	NULL
of	NULL
IL-6	NULL
.	NULL

Instillation	NULL
of	NULL
as	NULL
little	NULL
as	NULL
30	NULL
ng	NULL
Downloaded	NULL
from	NULL
www.physiclogy.org/journal/ajplung	NULL
(	NULL
173.236.240.127	NULL
)	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

L618	NULL
Cell	NULL
Counts	NULL
x	NULL
10®/ml	NULL
2	NULL
4	NULL
8	NULL
12	NULL
24	NULL
-	NULL
48	NULL
Time	NULL
(	NULL
hr	NULL
)	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Effect	NULL
of	NULL
IL-6	NULL
instillation	NULL
(	NULL
300	NULL
ng	NULL
)	NULL
on	NULL
bronchoalveolar	NULL
lavage	NULL
(	NULL
BAL	NULL
)	NULL
cellularity	NULL
.	NULL

BAL	NULL
was	NULL
performed	NULL
at	NULL
the	NULL
time	NULL
points	NULL
indicated	NULL
after	NULL
instillation	NULL
of	NULL
IL-6	NULL
(	NULL
n	NULL
=	NULL
4	NULL
;	NULL
filled	NULL
bars	NULL
)	NULL
or	NULL
saline	NULL
control	NULL
(	NULL
n	NULL
=	NULL
4	NULL
;	NULL
open	NULL
bars	NULL
)	NULL
.	NULL

Cells	NULL
in	NULL
the	NULL
BAL	NULL
fluid	NULL
were	NULL
counted	NULL
,	NULL
and	NULL
the	NULL
means	NULL
+	NULL
SE	NULL
were	NULL
plotted	NULL
.	NULL

Animals	NULL
that	NULL
received	NULL
IL-6	NULL
showed	NULL
a	NULL
significant	NULL
increase	NULL
in	NULL
cell	NULL
number	NULL
in	NULL
the	NULL
BAL	NULL
fluid	NULL
compared	NULL
with	NULL
animals	NULL
that	NULL
received	NULL
saline	NULL
at	NULL
4	NULL
,	NULL
8	NULL
,	NULL
12	NULL
,	NULL
24	NULL
,	NULL
and	NULL
48	NULL
h	NULL
(	NULL
*P	NULL
=	NULL
0.03	NULL
)	NULL
.	NULL

of	NULL
IL-6	NULL
increased	NULL
PMN	NULL
infiltration	NULL
by	NULL
7.1-fold	NULL
over	NULL
animals	NULL
receiving	NULL
saline	NULL
control	NULL
(	NULL
P	NULL
=	NULL
0.01	NULL
)	NULL
.	NULL

PMN	NULL
migration	NULL
into	NULL
alveolar	NULL
spaces	NULL
is	NULL
not	NULL
always	NULL
accompanied	NULL
by	NULL
injury	NULL
of	NULL
the	NULL
alveolar	NULL
capillary	NULL
wall	NULL
in	NULL
vivo	NULL
and	NULL
by	NULL
pulmonary	NULL
edema	NULL
(	NULL
8	NULL
,	NULL
10	NULL
,	NULL
19	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
IL-6-mediated	NULL
PMN	NULL
infiltration	NULL
caused	NULL
lung	NULL
damage	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
lungs	NULL
histologically	NULL
and	NULL
measured	NULL
lung	NULL
wet-to-dry	NULL
ratio	NULL
.	NULL

The	NULL
accumulation	NULL
of	NULL
PMN	NULL
was	NULL
accompanied	NULL
by	NULL
histological	NULL
signs	NULL
of	NULL
lung	NULL
injury	NULL
with	NULL
widened	NULL
interstitium	NULL
and	NULL
interstitial	NULL
and	NULL
alveolar	NULL
edema	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

The	NULL
wet-to-dry	NULL
ratio	NULL
increased	NULL
in	NULL
the	NULL
#	NULL
Saline	NULL
Instillation	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

Photomicrographs	NULL
of	NULL
sections	NULL
of	NULL
inflated	NULL
and	NULL
formaldehyde-fixed	NULL
lungs	NULL
.	NULL

Lungs	NULL
from	NULL
saline-treated	NULL
control	NULL
animals	NULL
(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
or	NULL
animals	NULL
treated	NULL
with	NULL
IL-6	NULL
(	NULL
300	NULL
ng	NULL
;	NULL
C	NULL
and	NULL
D	NULL
)	NULL
were	NULL
stained	NULL
for	NULL
myeloperoxidase	NULL
(	NULL
MPO	NULL
;	NULL
A	NULL
and	NULL
C	NULL
)	NULL
or	NULL
with	NULL
hematoxylin	NULL
and	NULL
eosin	NULL
(	NULL
H+E	NULL
;	NULL
B	NULL
and	NULL
D	NULL
)	NULL
and	NULL
examined	NULL
at	NULL
X400	NULL
magnification	NULL
.	NULL

IL-6	NULL
instillation	NULL
mag	NULL
,	NULL
INTERLEUKIN-6	NULL
IN	NULL
HEMORRHAGIC	NULL
SHOCK	NULL
IL-6-treated	NULL
animals	NULL
at	NULL
4	NULL
,	NULL
8	NULL
,	NULL
12	NULL
,	NULL
and	NULL
24	NULL
h	NULL
compared	NULL
with	NULL
control	NULL
animals	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
and	NULL
peaked	NULL
at	NULL
4	NULL
h	NULL
,	NULL
achieving	NULL
a	NULL
45	NULL
%	NULL
increase	NULL
over	NULL
normal	NULL
lung	NULL
(	NULL
P	NULL
=	NULL
0.03	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
minimum	NULL
amount	NULL
of	NULL
IL-6	NULL
necessary	NULL
to	NULL
cause	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
wet-to-dry	NULL
ratio	NULL
,	NULL
animals	NULL
were	NULL
examined	NULL
4	NULL
h	NULL
after	NULL
receiving	NULL
10	NULL
,	NULL
30	NULL
,	NULL
100	NULL
,	NULL
and	NULL
300	NULL
ng	NULL
of	NULL
IL-6	NULL
by	NULL
tracheal	NULL
instillation	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

We	NULL
observed	NULL
a	NULL
linear	NULL
increase	NULL
in	NULL
the	NULL
wet-to-dry	NULL
ratio	NULL
(	NULL
r	NULL
=	NULL
0.82	NULL
,	NULL
P	NULL
=	NULL
0.001	NULL
)	NULL
with	NULL
increasing	NULL
doses	NULL
of	NULL
IL-6	NULL
.	NULL

Instillation	NULL
of	NULL
as	NULL
little	NULL
as	NULL
30	NULL
ng	NULL
of	NULL
IL-6	NULL
increased	NULL
the	NULL
wet-to-dry	NULL
ratio	NULL
by	NULL
11	NULL
%	NULL
compared	NULL
with	NULL
animals	NULL
receiving	NULL
the	NULL
saline	NULL
control	NULL
(	NULL
P	NULL
=	NULL
0.04	NULL
)	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
IL-6	NULL
is	NULL
locally	NULL
produced	NULL
in	NULL
the	NULL
lungs	NULL
of	NULL
rats	NULL
subjected	NULL
to	NULL
resuscitated	NULL
HS	NULL
.	NULL

Levels	NULL
of	NULL
IL-6	NULL
mRNA	NULL
increased	NULL
with	NULL
increasing	NULL
duration	NULL
of	NULL
the	NULL
ischemic	NULL
phase	NULL
of	NULL
resuscitated	NULL
shock	NULL
.	NULL

IL-6	NULL
protein	NULL
was	NULL
located	NULL
in	NULL
bronchoepithelial	NULL
cells	NULL
and	NULL
in	NULL
alveolar	NULL
macrophages	NULL
.	NULL

Both	NULL
the	NULL
ischemic	NULL
and	NULL
resuscitation	NULL
phases	NULL
were	NULL
required	NULL
to	NULL
increase	NULL
IL-6	NULL
mRNA	NULL
levels	NULL
above	NULL
those	NULL
of	NULL
sham	NULL
control	NULL
animals	NULL
.	NULL

We	NULL
found	NULL
increased	NULL
activation	NULL
of	NULL
Stat3	NULL
compared	NULL
with	NULL
sham	NULL
animals	NULL
only	NULL
in	NULL
the	NULL
lungs	NULL
of	NULL
rats	NULL
subjected	NULL
to	NULL
resuscitated	NULL
HS	NULL
.	NULL

IL-6	NULL
mRNA	NULL
expression	NULL
and	NULL
Stat3	NULL
activation	NULL
demonstrated	NULL
similarly	NULL
rapid	NULL
kinetics	NULL
,	NULL
with	NULL
levels	NULL
of	NULL
both	NULL
peaking	NULL
1	NULL
h	NULL
after	NULL
the	NULL
onset	NULL
of	NULL
resuscitation	NULL
.	NULL

Intratracheal	NULL
instillation	NULL
of	NULL
IL-6	NULL
into	NULL
the	NULL
lungs	NULL
of	NULL
normal	NULL
rats	NULL
caused	NULL
PMN	NULL
infiltration	NULL
and	NULL
lung	NULL
damage	NULL
characterized	NULL
by	NULL
pulmonary	NULL
edema	NULL
.	NULL

Our	NULL
results	NULL
indicate	NULL
that	NULL
IL-6	NULL
alone	NULL
can	NULL
induce	NULL
lung	NULL
injury	NULL
and	NULL
suggest	NULL
7	NULL
“	NULL
ka	NULL
{	NULL
Au/FI	NULL
>	NULL
B	NULL
“	NULL
LT	NULL
‘	NULL
Downloaded	NULL
from	NULL
www.physiclogy.org/journal/ajplung	NULL
(	NULL
173.236.240.127	NULL
)	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

INTERLEUKIN-6	NULL
IN	NULL
HEMORRHAGIC	NULL
SHOCK	NULL
A	NULL
*	NULL
E	NULL
80	NULL
7	NULL
Jo	NULL
x	NULL
LL	NULL
.	NULL

X	NULL
&	NULL
9	NULL
-	NULL
60	NULL
{	NULL
*	NULL
g	NULL
4	NULL
#	NULL
40	NULL
6	NULL
mo	NULL
20	NULL
{	NULL
S	NULL
|	NULL
0	NULL
NL	NULL
O2	NULL
00040	NULL
8	NULL
420	NULL
240	NULL
48	NULL
B	NULL
TIME	NULL
(	NULL
hr	NULL
)	NULL
¥	NULL
80	NULL
7	NULL
3	NULL
*	NULL
©	NULL
fi	NULL
*	NULL
LL	NULL
o-	NULL
60	NULL
4	NULL
&	NULL
O	NULL
<	NULL
ped	NULL
|	NULL
€	NULL
40	NULL
A	NULL
.	NULL

6	NULL
Q	NULL
20	NULL
{	NULL
s	NULL
0	NULL
0	NULL
10	NULL
30	NULL
100	NULL
_	NULL
300	NULL
IL-6	NULL
(	NULL
ng	NULL
)	NULL
Fig	NULL
.	NULL

8	NULL
.	NULL

Effect	NULL
of	NULL
IL-6	NULL
instillation	NULL
on	NULL
accumulation	NULL
of	NULL
MPO-positive	NULL
polymorphonuclear	NULL
neutrophils	NULL
(	NULL
PMN	NULL
)	NULL
in	NULL
interstitium	NULL
and	NULL
alveolar	NULL
space	NULL
.	NULL

In	NULL
A	NULL
,	NULL
IL-6	NULL
(	NULL
300	NULL
ng	NULL
)	NULL
was	NULL
instilled	NULL
into	NULL
the	NULL
lungs	NULL
of	NULL
animals	NULL
(	NULL
n	NULL
=	NULL
4	NULL
)	NULL
,	NULL
and	NULL
the	NULL
animals	NULL
were	NULL
killed	NULL
at	NULL
the	NULL
time	NULL
points	NULL
indicated	NULL
.	NULL

Lungs	NULL
were	NULL
inflated	NULL
,	NULL
fixed	NULL
in	NULL
formaldehyde	NULL
,	NULL
sectioned	NULL
,	NULL
and	NULL
stained	NULL
for	NULL
MPO	NULL
.	NULL

MPO-stained	NULL
slides	NULL
were	NULL
examined	NULL
at	NULL
X400	NULL
magnification	NULL
.	NULL

Ten	NULL
random	NULL
fields	NULL
of	NULL
each	NULL
lung	NULL
specimen	NULL
were	NULL
blindly	NULL
scored	NULL
for	NULL
number	NULL
of	NULL
intensely	NULL
MPO-positive	NULL
PMN	NULL
.	NULL

Scores	NULL
were	NULL
pooled	NULL
,	NULL
and	NULL
the	NULL
means	NULL
+	NULL
SE	NULL
were	NULL
plotted	NULL
.	NULL

Means	NULL
were	NULL
increased	NULL
compared	NULL
with	NULL
normal	NULL
lung	NULL
at	NULL
4	NULL
,	NULL
8	NULL
,	NULL
12	NULL
,	NULL
and	NULL
24	NULL
h	NULL
(	NULL
*P	NULL
=	NULL
0.03	NULL
)	NULL
.	NULL

In	NULL
B	NULL
,	NULL
IL-6	NULL
was	NULL
instilled	NULL
into	NULL
the	NULL
lungs	NULL
of	NULL
animals	NULL
(	NULL
n	NULL
=	NULL
4	NULL
)	NULL
at	NULL
the	NULL
doses	NULL
indicated	NULL
.	NULL

Lungs	NULL
were	NULL
harvested	NULL
at	NULL
4	NULL
h	NULL
,	NULL
sectioned	NULL
,	NULL
and	NULL
stained	NULL
for	NULL
MPO	NULL
.	NULL

MPO-positive	NULL
PMN	NULL
were	NULL
quantitated	NULL
and	NULL
plotted	NULL
as	NULL
above	NULL
.	NULL

There	NULL
was	NULL
a	NULL
linear	NULL
increase	NULL
in	NULL
MPO-positive	NULL
cells	NULL
with	NULL
increasing	NULL
dose	NULL
(	NULL
r	NULL
=	NULL
0.74	NULL
;	NULL
P	NULL
<	NULL
0.03	NULL
)	NULL
4	NULL
h	NULL
after	NULL
IL-6	NULL
instillation	NULL
.	NULL

There	NULL
was	NULL
a	NULL
significant	NULL
increase	NULL
in	NULL
MPO-positive	NULL
PMN	NULL
in	NULL
the	NULL
interstitial	NULL
and	NULL
alveolar	NULL
spaces	NULL
after	NULL
administration	NULL
of	NULL
30	NULL
,	NULL
100	NULL
,	NULL
and	NULL
300	NULL
ng	NULL
IL-6	NULL
(	NULL
P	NULL
=	NULL
0.01	NULL
)	NULL
.	NULL

that	NULL
the	NULL
production	NULL
of	NULL
IL-6	NULL
may	NULL
contribute	NULL
to	NULL
ARDS	NULL
after	NULL
HS	NULL
.	NULL

We	NULL
previously	NULL
observed	NULL
that	NULL
the	NULL
lungs	NULL
of	NULL
animals	NULL
subjected	NULL
to	NULL
2.5	NULL
h	NULL
of	NULL
ischemia	NULL
followed	NULL
by	NULL
resuscitation	NULL
and	NULL
death	NULL
at	NULL
8	NULL
h	NULL
demonstrated	NULL
the	NULL
greatest	NULL
increase	NULL
in	NULL
PMN	NULL
infiltration	NULL
and	NULL
wet-to-dry	NULL
ratio	NULL
compared	NULL
with	NULL
sham	NULL
animals	NULL
(	NULL
15	NULL
)	NULL
.	NULL

PMN	NULL
accumulation	NULL
(	NULL
48	NULL
+	NULL
4.9	NULL
MPO-positive	NULL
PMN/X400	NULL
field	NULL
)	NULL
and	NULL
wet-to-dry	NULL
ratio	NULL
(	NULL
6.2	NULL
+	NULL
0.3	NULL
)	NULL
in	NULL
these	NULL
animals	NULL
were	NULL
similar	NULL
to	NULL
PMN	NULL
accumulation	NULL
(	NULL
61	NULL
+	NULL
12	NULL
and	NULL
73	NULL
+	NULL
11	NULL
)	NULL
and	NULL
wet-to-dry	NULL
ratio	NULL
(	NULL
6.05	NULL
+	NULL
0.25	NULL
and	NULL
5.69	NULL
+	NULL
0.28	NULL
)	NULL
observed	NULL
in	NULL
animals	NULL
4	NULL
and	NULL
12	NULL
h	NULL
,	NULL
respectively	NULL
,	NULL
after	NULL
IL-6	NULL
instillation	NULL
(	NULL
300	NULL
ng	NULL
)	NULL
.	NULL

The	NULL
pathogenesis	NULL
of	NULL
ARDS	NULL
is	NULL
thought	NULL
to	NULL
involve	NULL
a	NULL
diffuse	NULL
alveolar	NULL
capillary	NULL
injury	NULL
.	NULL

Activated	NULL
neutrophils	NULL
are	NULL
the	NULL
major	NULL
cellular	NULL
elements	NULL
that	NULL
mediate	NULL
acute	NULL
inflammation	NULL
and	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
pathogen	NULL
L619	NULL
esis	NULL
of	NULL
the	NULL
microvascular	NULL
injury	NULL
that	NULL
occurs	NULL
in	NULL
ARDS	NULL
(	NULL
29	NULL
)	NULL
.	NULL

The	NULL
results	NULL
from	NULL
our	NULL
study	NULL
indicate	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
IL-6	NULL
alone	NULL
can	NULL
lead	NULL
to	NULL
pulmonary	NULL
recruitment	NULL
of	NULL
PMN	NULL
and	NULL
pulmonary	NULL
edema	NULL
.	NULL

Thus	NULL
increased	NULL
IL-6	NULL
production	NULL
in	NULL
the	NULL
lung	NULL
of	NULL
patients	NULL
suffering	NULL
from	NULL
HS	NULL
may	NULL
be	NULL
an	NULL
additional	NULL
mechanism	NULL
that	NULL
contributes	NULL
to	NULL
PMN-induced	NULL
lung	NULL
injury	NULL
and	NULL
possibly	NULL
ARDS	NULL
.	NULL

IL-6	NULL
is	NULL
a	NULL
multifunctional	NULL
cytokine	NULL
that	NULL
is	NULL
part	NULL
of	NULL
the	NULL
acute	NULL
inflammatory	NULL
response	NULL
.	NULL

IL-6	NULL
stimulates	NULL
neutro-philia	NULL
and	NULL
thrombopoiesis	NULL
and	NULL
induces	NULL
the	NULL
synthesis	NULL
of	NULL
acute-phase	NULL
proteins	NULL
(	NULL
16	NULL
,	NULL
17	NULL
,	NULL
25	NULL
)	NULL
.	NULL

Sustained	NULL
elevations	NULL
of	NULL
IL-6	NULL
in	NULL
the	NULL
plasma	NULL
and	NULL
BAL	NULL
of	NULL
patients	NULL
suffering	NULL
from	NULL
ARDS	NULL
have	NULL
been	NULL
demonstrated	NULL
and	NULL
negatively	NULL
correlated	NULL
with	NULL
disease	NULL
outcome	NULL
and	NULL
patient	NULL
survival	NULL
(	NULL
5	NULL
,	NULL
21	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
acute	NULL
phase	NULL
of	NULL
ARDS	NULL
involves	NULL
PMN	NULL
recruitment	NULL
and	NULL
PMN-mediated	NULL
tissue	NULL
injury	NULL
,	NULL
there	NULL
has	NULL
been	NULL
little	NULL
evidence	NULL
to	NULL
suggest	NULL
that	NULL
IL-6	NULL
contributes	NULL
directly	NULL
to	NULL
these	NULL
processes	NULL
.	NULL

In	NULL
a	NULL
previous	NULL
study	NULL
,	NULL
overexpression	NULL
of	NULL
IL-6	NULL
in	NULL
the	NULL
pancreas	NULL
of	NULL
transgenic	NULL
mice	NULL
promoted	NULL
local	NULL
inflammation	NULL
(	NULL
4	NULL
)	NULL
.	NULL

However	NULL
,	NULL
our	NULL
study	NULL
is	NULL
the	NULL
first	NULL
to	NULL
demonstrate	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
IL-6	NULL
in	NULL
the	NULL
lung	NULL
alone	NULL
is	NULL
sufficient	NULL
to	NULL
promote	NULL
PMN	NULL
infiltration	NULL
and	NULL
pulmonary	NULL
edema	NULL
.	NULL

*	NULL
6.25	NULL
*	NULL
.2	NULL
©	NULL
-	NULL
sys	NULL
CC	NULL
~	NULL
*	NULL
al	NULL
G	NULL
-	NULL
sas	NULL
*	NULL
6	NULL
*	NULL
®	NULL
-	NULL
4.75	NULL
3	NULL
4.25	NULL
0	NULL
NL	NULL
200	NULL
40g	NULL
240	NULL
48	NULL
B	NULL
Time	NULL
(	NULL
hr	NULL
)	NULL
Kel	NULL
>	NULL
a	NULL
CC	NULL
2	NULL
O	NULL
6	NULL
to	NULL
por	NULL
S	NULL
0	NULL
_	NULL
o	NULL
10	NULL
_	NULL
30	NULL
IL-6	NULL
(	NULL
ng	NULL
)	NULL
100	NULL
-	NULL
300	NULL
Fig	NULL
.	NULL

9	NULL
.	NULL

Effect	NULL
of	NULL
IL-6	NULL
instillation	NULL
on	NULL
lung	NULL
wet-to-dry	NULL
ratio	NULL
.	NULL

In	NULL
A	NULL
,	NULL
IL-6	NULL
(	NULL
300	NULL
ng	NULL
)	NULL
was	NULL
intratracheally	NULL
instilled	NULL
into	NULL
the	NULL
lung	NULL
of	NULL
rats	NULL
(	NULL
n	NULL
=	NULL
5	NULL
;	NULL
filled	NULL
bars	NULL
)	NULL
by	NULL
syringe	NULL
injection	NULL
.	NULL

Control	NULL
rats	NULL
(	NULL
rn	NULL
=	NULL
6	NULL
;	NULL
open	NULL
bars	NULL
)	NULL
received	NULL
saline	NULL
control	NULL
alone	NULL
.	NULL

Animals	NULL
were	NULL
killed	NULL
at	NULL
the	NULL
times	NULL
indicated	NULL
,	NULL
and	NULL
the	NULL
left	NULL
lung	NULL
was	NULL
removed	NULL
for	NULL
determination	NULL
of	NULL
wet-to-dry	NULL
ratio	NULL
.	NULL

Data	NULL
presented	NULL
are	NULL
means	NULL
+	NULL
SE	NULL
.	NULL

The	NULL
wet-to-dry	NULL
ratio	NULL
was	NULL
significantly	NULL
increased	NULL
in	NULL
the	NULL
IL-6-treated	NULL
animals	NULL
compared	NULL
with	NULL
control	NULL
animals	NULL
at	NULL
4	NULL
,	NULL
8	NULL
,	NULL
12	NULL
,	NULL
and	NULL
24	NULL
h	NULL
(	NULL
*P	NULL
=	NULL
0.03	NULL
,	NULL
P	NULL
=	NULL
0.04	NULL
,	NULL
P	NULL
=	NULL
0.02	NULL
,	NULL
and	NULL
P	NULL
=	NULL
0.03	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

In	NULL
B	NULL
,	NULL
IL-6	NULL
at	NULL
the	NULL
doses	NULL
indicated	NULL
was	NULL
instilled	NULL
into	NULL
the	NULL
lungs	NULL
of	NULL
animals	NULL
(	NULL
r	NULL
=	NULL
5	NULL
)	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Animals	NULL
were	NULL
killed	NULL
at	NULL
4	NULL
h	NULL
,	NULL
and	NULL
the	NULL
left	NULL
lung	NULL
was	NULL
removed	NULL
for	NULL
determination	NULL
of	NULL
wet-to-dry	NULL
ratio	NULL
.	NULL

The	NULL
wet-to-dry	NULL
ratio	NULL
increased	NULL
with	NULL
increasing	NULL
IL-6	NULL
dose	NULL
(	NULL
r	NULL
=	NULL
0.82	NULL
;	NULL
P	NULL
=	NULL
0.001	NULL
)	NULL
.	NULL

A	NULL
significant	NULL
increase	NULL
in	NULL
lung	NULL
wet-to-dry	NULL
ratio	NULL
was	NULL
detected	NULL
after	NULL
administration	NULL
of	NULL
an	NULL
IL-6	NULL
dose	NULL
at	NULL
30	NULL
,	NULL
100	NULL
,	NULL
and	NULL
300	NULL
ng	NULL
(	NULL
*P	NULL
=	NULL
0.03	NULL
)	NULL
.	NULL

Downloaded	NULL
from	NULL
www.physiclogy.org/journal/ajplung	NULL
(	NULL
173.236.240.127	NULL
)	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

L620	NULL
In	NULL
contrast	NULL
to	NULL
our	NULL
findings	NULL
of	NULL
acute	NULL
inflammation	NULL
after	NULL
IL-6	NULL
instillation	NULL
,	NULL
several	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
IL-6	NULL
has	NULL
anti-inflammatory	NULL
effects	NULL
.	NULL

Exposure	NULL
of	NULL
cells	NULL
to	NULL
IL-6	NULL
or	NULL
intraperitoneal	NULL
injection	NULL
of	NULL
IL-6	NULL
was	NULL
demonstrated	NULL
to	NULL
inhibit	NULL
tumor	NULL
necrosis	NULL
factor-	NULL
«	NULL
and	NULL
IL-1B	NULL
production	NULL
and	NULL
to	NULL
protect	NULL
against	NULL
LPS	NULL
toxicity	NULL
in	NULL
vitro	NULL
(	NULL
1	NULL
)	NULL
and	NULL
in	NULL
vivo	NULL
,	NULL
respectively	NULL
(	NULL
3	NULL
)	NULL
.	NULL

IL-6	NULL
also	NULL
decreased	NULL
neutrophil	NULL
infiltration	NULL
into	NULL
the	NULL
lung	NULL
in	NULL
a	NULL
mouse	NULL
model	NULL
of	NULL
chronic	NULL
pneumonitis	NULL
elicited	NULL
by	NULL
fungal	NULL
exposure	NULL
(	NULL
9	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
intraperitoneal	NULL
injection	NULL
of	NULL
IL-6	NULL
antibody	NULL
and	NULL
intratracheal	NULL
administration	NULL
of	NULL
IL-6	NULL
(	NULL
5,000	NULL
units	NULL
)	NULL
decreased	NULL
BAL	NULL
cellularity	NULL
and	NULL
peripheral	NULL
blood	NULL
neutro-philia	NULL
.	NULL

However	NULL
,	NULL
these	NULL
models	NULL
of	NULL
LPS	NULL
toxicity	NULL
and	NULL
chronic	NULL
inflammation	NULL
differ	NULL
substantially	NULL
in	NULL
either	NULL
the	NULL
nature	NULL
or	NULL
duration	NULL
of	NULL
the	NULL
insult	NULL
from	NULL
the	NULL
acute	NULL
inflammation	NULL
occurring	NULL
in	NULL
our	NULL
models	NULL
of	NULL
HS	NULL
and	NULL
IL-6	NULL
instillation	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
IL-6	NULL
contributes	NULL
to	NULL
tissue	NULL
recruitment	NULL
of	NULL
PMN	NULL
by	NULL
induction	NULL
of	NULL
chemokines	NULL
(	NULL
26	NULL
)	NULL
;	NULL
however	NULL
,	NULL
little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
mechanisms	NULL
of	NULL
IL-6-mediated	NULL
local	NULL
chemokine	NULL
produc-tion	NULL
.	NULL

The	NULL
promoter	NULL
region	NULL
of	NULL
IP-10	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
C-X-C	NULL
subgroup	NULL
of	NULL
chemokines	NULL
,	NULL
contains	NULL
an	NULL
interferon-stimulated	NULL
response	NULL
element	NULL
capable	NULL
of	NULL
binding	NULL
STAT	NULL
proteins	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Our	NULL
findings	NULL
in	NULL
HS	NULL
that	NULL
IL-6	NULL
is	NULL
produced	NULL
in	NULL
the	NULL
lung	NULL
and	NULL
Stat3	NULL
is	NULL
locally	NULL
activated	NULL
raise	NULL
the	NULL
possibility	NULL
that	NULL
IL-6-activated	NULL
Stat3	NULL
may	NULL
contribute	NULL
to	NULL
local	NULL
chemokine	NULL
production	NULL
through	NULL
transcriptional	NULL
activation	NULL
of	NULL
chemokine	NULL
genes	NULL
such	NULL
as	NULL
IL-8	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
IL-6	NULL
instilled	NULL
into	NULL
the	NULL
lung	NULL
of	NULL
rats	NULL
in	NULL
our	NULL
studies	NULL
ranged	NULL
from	NULL
10	NULL
to	NULL
300	NULL
ng	NULL
.	NULL

We	NULL
observed	NULL
a	NULL
significant	NULL
increase	NULL
in	NULL
lung	NULL
wet-to-dry	NULL
ratio	NULL
and	NULL
PMN	NULL
infiltration	NULL
after	NULL
instillation	NULL
of	NULL
30	NULL
,	NULL
100	NULL
,	NULL
and	NULL
300	NULL
ng	NULL
.	NULL

In	NULL
patients	NULL
with	NULL
ARDS	NULL
,	NULL
levels	NULL
of	NULL
IL-6	NULL
in	NULL
BAL	NULL
fluid	NULL
exceeded	NULL
20	NULL
ng/ml	NULL
,	NULL
and	NULL
IL-6	NULL
levels	NULL
in	NULL
plasma	NULL
exceeded	NULL
1.5	NULL
ng/ml	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Levels	NULL
of	NULL
IL-6	NULL
in	NULL
lung	NULL
tissue	NULL
in	NULL
humans	NULL
or	NULL
animals	NULL
have	NULL
not	NULL
been	NULL
reported	NULL
.	NULL

Where	NULL
simultaneous	NULL
lung	NULL
tissue	NULL
and	NULL
plasma	NULL
levels	NULL
of	NULL
a	NULL
cytokine	NULL
have	NULL
been	NULL
determined	NULL
,	NULL
such	NULL
as	NULL
IL-1B	NULL
levels	NULL
in	NULL
steroid-induced	NULL
Pneumocystis	NULL
carinii	NULL
pneumonia	NULL
,	NULL
a	NULL
lung-to-plasma	NULL
gradient	NULL
greater	NULL
than	NULL
60	NULL
was	NULL
found	NULL
(	NULL
24	NULL
)	NULL
.	NULL

If	NULL
such	NULL
a	NULL
gradient	NULL
occurred	NULL
for	NULL
IL-6	NULL
,	NULL
the	NULL
lung	NULL
tissue	NULL
levels	NULL
of	NULL
IL-6	NULL
in	NULL
patients	NULL
with	NULL
ARDS	NULL
would	NULL
exceed	NULL
90	NULL
ng/ml	NULL
.	NULL

Conse-quently	NULL
,	NULL
the	NULL
doses	NULL
used	NULL
in	NULL
our	NULL
studies	NULL
may	NULL
very	NULL
well	NULL
reflect	NULL
lung	NULL
tissue	NULL
levels	NULL
of	NULL
IL-6	NULL
achievable	NULL
in	NULL
acute	NULL
inflammatory	NULL
states	NULL
such	NULL
as	NULL
early	NULL
ARDS	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
IL-6	NULL
administered	NULL
into	NULL
the	NULL
lungs	NULL
results	NULL
in	NULL
systemic	NULL
PMN	NULL
activation	NULL
and	NULL
PMN-mediated	NULL
damage	NULL
to	NULL
other	NULL
organs	NULL
such	NULL
as	NULL
the	NULL
liver	NULL
,	NULL
we	NULL
measured	NULL
serum	NULL
levels	NULL
of	NULL
liver	NULL
enzymes	NULL
,	NULL
including	NULL
alanine	NULL
aminotransferase	NULL
,	NULL
aspartate	NULL
aminotransferase	NULL
,	NULL
lactate	NULL
dehy-drogenase	NULL
,	NULL
and	NULL
alkaline	NULL
phosphatase	NULL
.	NULL

Liver	NULL
enzymes	NULL
were	NULL
within	NULL
normal	NULL
limits	NULL
in	NULL
all	NULL
IL-6	NULL
instillation	NULL
groups	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
histological	NULL
examination	NULL
of	NULL
representative	NULL
cross	NULL
sections	NULL
of	NULL
liver	NULL
did	NULL
not	NULL
demonstrate	NULL
increased	NULL
PMN	NULL
infiltration	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
IL-6	NULL
delivered	NULL
intratracheally	NULL
leads	NULL
to	NULL
lung	NULL
injury	NULL
as	NULL
a	NULL
result	NULL
of	NULL
its	NULL
local	NULL
effects	NULL
on	NULL
PMN	NULL
recruitment	NULL
and	NULL
activation	NULL
and	NULL
not	NULL
as	NULL
a	NULL
consequence	NULL
of	NULL
a	NULL
systemic	NULL
effect	NULL
of	NULL
IL-6	NULL
on	NULL
PMN	NULL
.	NULL

INTERLEUKIN-6	NULL
IN	NULL
HEMORRHAGIC	NULL
SHOCK	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
GM-53789	NULL
and	NULL
CA-72261	NULL
and	NULL
by	NULL
the	NULL
Deutsche	NULL
Forschungsgemein-schaft	NULL
HI	NULL
614/1-1	NULL
and	NULL
Ka	NULL
1270/1-1	NULL
.	NULL

Address	NULL
for	NULL
reprint	NULL
requests	NULL
:	NULL
D.	NULL
J.	NULL
Tweardy	NULL
,	NULL
W1052	NULL
Biomedical	NULL
Science	NULL
Tower	NULL
,	NULL
Univ	NULL
.	NULL

of	NULL
Pittsburgh	NULL
Cancer	NULL
Institute	NULL
,	NULL
200	NULL
Lothrop	NULL
St.	NULL
,	NULL
Pittsburgh	NULL
,	NULL
PA	NULL
15213	NULL
.	NULL

Received	NULL
30	NULL
January	NULL
1998	NULL
;	NULL
accepted	NULL
in	NULL
final	NULL
form	NULL
13	NULL
May	NULL
1998	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Aderka	NULL
,	NULL
D.	NULL
,	NULL
J.	NULL
M.	NULL
Le	NULL
,	NULL
and	NULL
J.	NULL
Vilcek	NULL
.	NULL

IL-6	NULL
inhibits	NULL
lipopolysac-charide-induced	NULL
tumor	NULL
necrosis	NULL
factor	NULL
production	NULL
in	NULL
cultured	NULL
human	NULL
monocytes	NULL
,	NULL
U937	NULL
cells	NULL
,	NULL
and	NULL
in	NULL
mice	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

143	NULL
:	NULL
3517-3523	NULL
,	NULL
1989	NULL
.	NULL

2	NULL
.	NULL

Akira	NULL
,	NULL
S.	NULL
,	NULL
Y.	NULL
Nishio	NULL
,	NULL
M.	NULL
Inoue	NULL
,	NULL
X.	NULL
J.	NULL
Wang	NULL
,	NULL
S.	NULL
Wei	NULL
,	NULL
T.	NULL
Matsusaka	NULL
,	NULL
K.	NULL
Yoshida	NULL
,	NULL
T.	NULL
Sudo	NULL
,	NULL
M.	NULL
Naruto	NULL
,	NULL
and	NULL
T.	NULL
Kishi-moto	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
APRF	NULL
,	NULL
a	NULL
novel	NULL
IFN-stimulated	NULL
gene	NULL
factor	NULL
3	NULL
p91-related	NULL
transcription	NULL
factor	NULL
involved	NULL
in	NULL
the	NULL
gp130-mediated	NULL
signaling	NULL
pathway	NULL
.	NULL

Cell	NULL
77	NULL
:	NULL
63-71	NULL
,	NULL
1994	NULL
.	NULL

3	NULL
.	NULL

Barton	NULL
,	NULL
B.	NULL
E.	NULL
,	NULL
and	NULL
J.	NULL
V.	NULL
Jackson	NULL
.	NULL

Protective	NULL
role	NULL
of	NULL
interleukin	NULL
6	NULL
in	NULL
the	NULL
lipopolysaccharide-galactosamine	NULL
septic	NULL
shock	NULL
model	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

61	NULL
:	NULL
1496-1499	NULL
,	NULL
1993	NULL
.	NULL

4	NULL
.	NULL

Campbell	NULL
,	NULL
I.	NULL
L.	NULL
,	NULL
M.	NULL
V.	NULL
Hobbs	NULL
,	NULL
J.	NULL
Dockter	NULL
,	NULL
M.	NULL
B.	NULL
Oldstone	NULL
,	NULL
and	NULL
J.	NULL
Allison	NULL
.	NULL

Islet	NULL
inflammation	NULL
and	NULL
hyperplasia	NULL
induced	NULL
by	NULL
the	NULL
pancreatic	NULL
islet-specific	NULL
overexpression	NULL
of	NULL
interleukin-6	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

145	NULL
:	NULL
157-166	NULL
,	NULL
1994	NULL
.	NULL

5	NULL
.	NULL

Casey	NULL
,	NULL
L.	NULL
C.	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

Balk	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Bone	NULL
.	NULL

Plasma	NULL
cytokine	NULL
and	NULL
endotoxin	NULL
levels	NULL
correlate	NULL
with	NULL
survival	NULL
in	NULL
patients	NULL
with	NULL
the	NULL
sepsis	NULL
syndrome	NULL
.	NULL

Ann	NULL
.	NULL

Intern	NULL
.	NULL

Med	NULL
.	NULL

119	NULL
:	NULL
771-778	NULL
,	NULL
1993	NULL
.	NULL

6	NULL
.	NULL

Chakraborty	NULL
,	NULL
A.	NULL
,	NULL
S.	NULL
M.	NULL
White	NULL
,	NULL
T.	NULL
S.	NULL
Schaefer	NULL
,	NULL
E.	NULL
D.	NULL
Ball	NULL
,	NULL
K.	NULL
F.	NULL
Dyer	NULL
,	NULL
and	NULL
D.	NULL
J.	NULL
Tweardy	NULL
.	NULL

Granulocyte	NULL
colony-stimulating	NULL
factor	NULL
activation	NULL
of	NULL
StatS-alpha	NULL
and	NULL
Stat3-beta	NULL
in	NULL
immature	NULL
normal	NULL
and	NULL
leukemic	NULL
human	NULL
myeloid	NULL
cells	NULL
.	NULL

Blood	NULL
88	NULL
:	NULL
2442-2449	NULL
,	NULL
1996	NULL
.	NULL

7	NULL
.	NULL

Chomezynski	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
N.	NULL
Sacchi	NULL
.	NULL

Single-step	NULL
method	NULL
of	NULL
RNA	NULL
isolation	NULL
by	NULL
acid	NULL
guanidinium	NULL
thiocyanate-phenol-chloroform	NULL
extraction	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

162	NULL
:	NULL
156-159	NULL
,	NULL
1987	NULL
.	NULL

8	NULL
.	NULL

Delclaux	NULL
,	NULL
C.	NULL
,	NULL
S.	NULL
Rezaiguia-Delclaux	NULL
,	NULL
C.	NULL
Delacourt	NULL
,	NULL
C.	NULL
Brun-Buisson	NULL
,	NULL
C.	NULL
Lafuma	NULL
,	NULL
and	NULL
A.	NULL
Harf	NULL
.	NULL

Alveolar	NULL
neutrophils	NULL
in	NULL
endotoxin-induced	NULL
and	NULL
bacteria-induced	NULL
acute	NULL
lung	NULL
injury	NULL
in	NULL
rats	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Physiol	NULL
.	NULL

273	NULL
(	NULL
Lung	NULL
Cell	NULL
.	NULL

Mol	NULL
.	NULL

Physiol	NULL
.	NULL

17	NULL
)	NULL
;	NULL
L104-L112	NULL
,	NULL
1997	NULL
.	NULL

9	NULL
.	NULL

Denis	NULL
,	NULL
M.	NULL
Interleukin-6	NULL
in	NULL
mouse	NULL
hypersensitivity	NULL
pneumonitis	NULL
:	NULL
changes	NULL
in	NULL
lung	NULL
free	NULL
cells	NULL
following	NULL
depletion	NULL
of	NULL
endogenous	NULL
IL-6	NULL
or	NULL
direct	NULL
administration	NULL
of	NULL
IL-6	NULL
.	NULL

J.	NULL
Leukoc	NULL
.	NULL

Biol	NULL
.	NULL

52	NULL
:	NULL
197-201	NULL
,	NULL
1992	NULL
.	NULL

10	NULL
.	NULL

Garat	NULL
,	NULL
C.	NULL
,	NULL
S.	NULL
Rezaiguia	NULL
,	NULL
M.	NULL
Meignan	NULL
,	NULL
M.	NULL
P.	NULL
D'Ortho	NULL
,	NULL
A.	NULL
Harf	NULL
,	NULL
M.	NULL
A.	NULL
Matthay	NULL
,	NULL
and	NULL
C.	NULL
Jayr	NULL
.	NULL

Alveolar	NULL
endotoxin	NULL
increases	NULL
alveolar	NULL
liquid	NULL
clearance	NULL
in	NULL
rats	NULL
.	NULL

J.	NULL
Appl	NULL
.	NULL

Physiol	NULL
.	NULL

79	NULL
:	NULL
2021-2028	NULL
,	NULL
1995	NULL
.	NULL

11	NULL
.	NULL

Hanker	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
P.	NULL
E.	NULL
Yates	NULL
,	NULL
C.	NULL
B.	NULL
Metz	NULL
,	NULL
and	NULL
A.	NULL
Rustioni	NULL
.	NULL

A	NULL
new	NULL
specific	NULL
,	NULL
sensitive	NULL
and	NULL
non-carcinogenic	NULL
reagent	NULL
for	NULL
the	NULL
demonstration	NULL
of	NULL
horseradish	NULL
peroxidase	NULL
.	NULL

Histochem	NULL
.	NULL

J	NULL
.	NULL

9	NULL
:	NULL
789-792	NULL
,	NULL
1977	NULL
.	NULL

12	NULL
.	NULL

Hierholzer	NULL
,	NULL
C.	NULL
,	NULL
B.	NULL
Harbrecht	NULL
,	NULL
J.	NULL
M.	NULL
Menezes	NULL
,	NULL
J.	NULL
Kane	NULL
,	NULL
J.	NULL
MacMicking	NULL
,	NULL
C.	NULL
F.	NULL
Nathan	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Peitzman	NULL
,	NULL
T.	NULL
R.	NULL
Billiar	NULL
,	NULL
and	NULL
D.	NULL
J.	NULL
Tweardy	NULL
.	NULL

Essential	NULL
role	NULL
of	NULL
induced	NULL
nitric	NULL
oxide	NULL
in	NULL
the	NULL
initiation	NULL
of	NULL
the	NULL
inflammatory	NULL
response	NULL
following	NULL
hemorrhagic	NULL
shock	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

187	NULL
:	NULL
917-928	NULL
,	NULL
1998	NULL
.	NULL

13	NULL
.	NULL

Hierholzer	NULL
,	NULL
C.	NULL
,	NULL
J.	NULL
Kalff	NULL
,	NULL
T.	NULL
Billiar	NULL
,	NULL
and	NULL
D.	NULL
Tweardy	NULL
.	NULL

Activation	NULL
of	NULL
STAT	NULL
proteins	NULL
in	NULL
the	NULL
lung	NULL
of	NULL
rats	NULL
following	NULL
resuscitation	NULL
from	NULL
hemorrhagic	NULL
shock	NULL
.	NULL

Arch	NULL
.	NULL

Orthop	NULL
.	NULL

Trauma	NULL
Surg	NULL
.	NULL

In	NULL
press	NULL
.	NULL

14	NULL
.	NULL

Hierholzer	NULL
,	NULL
C.	NULL
,	NULL
E.	NULL
Kelly	NULL
,	NULL
V.	NULL
Lyons	NULL
,	NULL
E.	NULL
Roedling	NULL
,	NULL
P.	NULL
Davies	NULL
,	NULL
T.	NULL
R.	NULL
Billiar	NULL
,	NULL
and	NULL
D.	NULL
J.	NULL
Tweardy	NULL
.	NULL

Granulocyte	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
G-CSF	NULL
)	NULL
instillation	NULL
into	NULL
rat	NULL
lungs	NULL
mediates	NULL
neutrophil	NULL
recruitment	NULL
,	NULL
pulmonary	NULL
edema	NULL
,	NULL
and	NULL
hypoxia	NULL
.	NULL

J.	NULL
Leukoc	NULL
.	NULL

Biol	NULL
.	NULL

63	NULL
:	NULL
169-174	NULL
,	NULL
1998	NULL
.	NULL

15	NULL
.	NULL

Hierholzer	NULL
,	NULL
C.	NULL
,	NULL
E.	NULL
Kelly	NULL
,	NULL
K.	NULL
Tsukada	NULL
,	NULL
E.	NULL
Loeffert	NULL
,	NULL
S.	NULL
Watkins	NULL
,	NULL
T.	NULL
Billiar	NULL
,	NULL
and	NULL
D.	NULL
Tweardy	NULL
.	NULL

Hemorrhagic	NULL
shock	NULL
induces	NULL
G-CSF	NULL
expression	NULL
in	NULL
bronchial	NULL
epithelium	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Physiol	NULL
.	NULL

273	NULL
(	NULL
Lung	NULL
Cell	NULL
.	NULL

Mol	NULL
.	NULL

Physiol	NULL
.	NULL

17	NULL
)	NULL
;	NULL
L1058-L1064	NULL
,	NULL
1997	NULL
.	NULL

16	NULL
.	NULL

Kishimoto	NULL
,	NULL
T.	NULL
The	NULL
biology	NULL
of	NULL
interleukin-6	NULL
.	NULL

Blood	NULL
74	NULL
:	NULL
1-10	NULL
,	NULL
1989	NULL
.	NULL

Downloaded	NULL
from	NULL
www.physiclogy.org/journal/ajplung	NULL
(	NULL
173.236.240.127	NULL
)	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

INTERLEUKIN-6	NULL
IN	NULL
HEMORRHAGIC	NULL
SHOCK	NULL
Kishimoto	NULL
,	NULL
T.	NULL
Interleukin-6	NULL
and	NULL
its	NULL
receptor	NULL
in	NULL
autoimmunity	NULL
.	NULL

J.	NULL
Autoimmun	NULL
.	NULL

5	NULL
:	NULL
123-132	NULL
,	NULL
1992	NULL
.	NULL

Kishimoto	NULL
,	NULL
T.	NULL
,	NULL
T.	NULL
Taga	NULL
,	NULL
and	NULL
S.	NULL
Akira	NULL
.	NULL

Cytokine	NULL
signal	NULL
transduc-tion	NULL
.	NULL

Cell	NULL
76	NULL
:	NULL
2583-262	NULL
,	NULL
1994	NULL
.	NULL

Martin	NULL
,	NULL
T.	NULL
R.	NULL
,	NULL
B.	NULL
P.	NULL
Pistorese	NULL
,	NULL
E.	NULL
Y.	NULL
Chi	NULL
,	NULL
R.	NULL
B.	NULL
Goodman	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Matthay	NULL
.	NULL

Effects	NULL
of	NULL
leukotriene	NULL
B4	NULL
in	NULL
the	NULL
human	NULL
lung	NULL
.	NULL

Recruitment	NULL
of	NULL
neutrophils	NULL
into	NULL
the	NULL
alveolar	NULL
spaces	NULL
without	NULL
a	NULL
change	NULL
in	NULL
protein	NULL
permeability	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

84	NULL
:	NULL
1609-1619	NULL
,	NULL
1989	NULL
.	NULL

Marty	NULL
,	NULL
C.	NULL
,	NULL
B.	NULL
Misset	NULL
,	NULL
F.	NULL
Tamion	NULL
,	NULL
C.	NULL
Fitting	NULL
,	NULL
J.	NULL
Carlet	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Cavaillon	NULL
.	NULL

Circulating	NULL
interleukin-8	NULL
concentrations	NULL
in	NULL
patients	NULL
with	NULL
multiple	NULL
organ	NULL
failure	NULL
of	NULL
septic	NULL
and	NULL
nonseptic	NULL
origin	NULL
.	NULL

Crit	NULL
.	NULL

Care	NULL
Med	NULL
.	NULL

22	NULL
:	NULL
678-679	NULL
,	NULL
1994	NULL
.	NULL

Meduri	NULL
,	NULL
G.	NULL
U.	NULL
,	NULL
S.	NULL
Headley	NULL
,	NULL
G.	NULL
Kohler	NULL
,	NULL
F.	NULL
Stentz	NULL
,	NULL
E.	NULL
Tolley	NULL
,	NULL
R.	NULL
Umberger	NULL
,	NULL
and	NULL
K.	NULL
Leeper	NULL
.	NULL

Persistent	NULL
elevation	NULL
of	NULL
inflammatory	NULL
cytokines	NULL
predicts	NULL
a	NULL
poor	NULL
outcome	NULL
in	NULL
ARDS	NULL
.	NULL

Plasma	NULL
IL-1	NULL
beta	NULL
and	NULL
IL-6	NULL
levels	NULL
are	NULL
consistent	NULL
and	NULL
efficient	NULL
predictors	NULL
of	NULL
outcome	NULL
over	NULL
time	NULL
.	NULL

Chest	NULL
107	NULL
:	NULL
1062-1073	NULL
,	NULL
1995	NULL
.	NULL

Meduri	NULL
,	NULL
G.	NULL
U.	NULL
,	NULL
S.	NULL
Headley	NULL
,	NULL
E.	NULL
Tolley	NULL
,	NULL
M.	NULL
Shelby	NULL
,	NULL
F.	NULL
Stentz	NULL
,	NULL
and	NULL
A.	NULL
Postlethwaite	NULL
.	NULL

Plasma	NULL
and	NULL
BAL	NULL
cytokine	NULL
response	NULL
to	NULL
corticosteroid	NULL
rescue	NULL
treatment	NULL
in	NULL
late	NULL
ARDS	NULL
.	NULL

Chest	NULL
108	NULL
:	NULL
1315-1325	NULL
,	NULL
1995	NULL
.	NULL

Nazar	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
G.	NULL
Cheng	NULL
,	NULL
H.	NULL
S.	NULL
Shin	NULL
,	NULL
P.	NULL
N.	NULL
Brothers	NULL
,	NULL
S.	NULL
Dhib-Jalbut	NULL
,	NULL
M.	NULL
L.	NULL
Shin	NULL
,	NULL
and	NULL
P.	NULL
Vanguri	NULL
.	NULL

Induction	NULL
of	NULL
IP-10	NULL
chemokine	NULL
promoter	NULL
by	NULL
measles	NULL
virus	NULL
:	NULL
comparison	NULL
with	NULL
inter-feron-gamma	NULL
shows	NULL
the	NULL
use	NULL
of	NULL
the	NULL
same	NULL
response	NULL
element	NULL
but	NULL
with	NULL
differential	NULL
DNA-protein	NULL
binding	NULL
profiles	NULL
.	NULL

J.	NULL
Neurocimmu-nol	NULL
.	NULL

T7	NULL
:	NULL
116-127	NULL
,	NULL
1997	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

L621	NULL
Perenboom	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
P.	NULL
Beckers	NULL
,	NULL
J.	NULL
W.	NULL
Van	NULL
Der	NULL
Meer	NULL
,	NULL
A.	NULL
C.	NULL
Van	NULL
Schijndel	NULL
,	NULL
W.	NULL
J.	NULL
Oyen	NULL
,	NULL
F.	NULL
H.	NULL
Corstens	NULL
,	NULL
and	NULL
R.	NULL
W.	NULL
Sauerwein	NULL
.	NULL

Pro-inflammatory	NULL
cytokines	NULL
in	NULL
lung	NULL
and	NULL
blood	NULL
during	NULL
steroid-induced	NULL
Preumocystis	NULL
carinii	NULL
pneumonia	NULL
in	NULL
rats	NULL
.	NULL

J.	NULL
Leukoc	NULL
.	NULL

Biol	NULL
.	NULL

60	NULL
:	NULL
710-715	NULL
,	NULL
1996	NULL
.	NULL

Romani	NULL
,	NULL
L.	NULL
,	NULL
A.	NULL
Mencacci	NULL
,	NULL
E.	NULL
Cenci	NULL
,	NULL
R.	NULL
Spaccapelo	NULL
,	NULL
C.	NULL
Toniatti	NULL
,	NULL
P.	NULL
Puccetti	NULL
,	NULL
F.	NULL
Bistoni	NULL
,	NULL
and	NULL
V.	NULL
Poli	NULL
.	NULL

Impaired	NULL
neutrophil	NULL
response	NULL
and	NULL
CD4+	NULL
T	NULL
helper	NULL
cell	NULL
1	NULL
development	NULL
in	NULL
interleukin	NULL
6-deficient	NULL
mice	NULL
infected	NULL
with	NULL
Candida	NULL
albicans	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

183	NULL
:	NULL
1345-1355	NULL
,	NULL
1996	NULL
.	NULL

Romano	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Sironi	NULL
,	NULL
C.	NULL
Toniatti	NULL
,	NULL
N.	NULL
Polentarutti	NULL
,	NULL
P.	NULL
Fruscella	NULL
,	NULL
P.	NULL
Ghezzi	NULL
,	NULL
R.	NULL
Faggioni	NULL
,	NULL
W.	NULL
Luini	NULL
,	NULL
V.	NULL
van	NULL
Hins-bergh	NULL
,	NULL
S.	NULL
Sozzani	NULL
,	NULL
F.	NULL
Bussolino	NULL
,	NULL
V.	NULL
Poli	NULL
,	NULL
G.	NULL
Ciliberto	NULL
,	NULL
and	NULL
A.	NULL
Mantovani	NULL
.	NULL

Role	NULL
of	NULL
IL-6	NULL
and	NULL
its	NULL
soluble	NULL
receptor	NULL
in	NULL
induction	NULL
of	NULL
chemokines	NULL
and	NULL
leukocyte	NULL
recruitment	NULL
.	NULL

Immunity	NULL
6	NULL
:	NULL
315-325	NULL
,	NULL
1997	NULL
.	NULL

Schaefer	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
L.	NULL
K.	NULL
Sanders	NULL
,	NULL
and	NULL
D.	NULL
Nathans	NULL
.	NULL

Cooperative	NULL
transcriptional	NULL
activity	NULL
of	NULL
Jun	NULL
and	NULL
Stat3	NULL
beta	NULL
,	NULL
a	NULL
short	NULL
form	NULL
of	NULL
Stat3	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

USA	NULL
92	NULL
:	NULL
9097-9101	NULL
,	NULL
1995	NULL
.	NULL

Strieter	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
Kunkel	NULL
.	NULL

Acute	NULL
lung	NULL
injury	NULL
:	NULL
the	NULL
role	NULL
of	NULL
cytokines	NULL
in	NULL
the	NULL
elicitation	NULL
of	NULL
neutrophils	NULL
204	NULL
.	NULL

J.	NULL
Investig	NULL
.	NULL

Med	NULL
.	NULL

42	NULL
:	NULL
640-651	NULL
,	NULL
1994	NULL
.	NULL

[	NULL
Corrigenda	NULL
.	NULL

J.	NULL
Investig	NULL
.	NULL

Med	NULL
.	NULL

43	NULL
:	NULL
204	NULL
,	NULL
1995	NULL
]	NULL
.	NULL

Tate	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Repine	NULL
.	NULL

Neutrophils	NULL
and	NULL
the	NULL
adult	NULL
respiratory	NULL
distress	NULL
syndrome	NULL
.	NULL

Am	NULL
.	NULL

Rev	NULL
.	NULL

Respir	NULL
.	NULL

Dis	NULL
.	NULL

128	NULL
:	NULL
552-559	NULL
,	NULL
1983	NULL
.	NULL

Wagner	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
T.	NULL
E.	NULL
Hayes	NULL
,	NULL
C.	NULL
J.	NULL
Hoban	NULL
,	NULL
and	NULL
B.	NULL
H.	NULL
Cochran	NULL
.	NULL

The	NULL
SIF	NULL
binding	NULL
element	NULL
confers	NULL
sis/PDGF	NULL
inducibility	NULL
onto	NULL
the	NULL
c-fos	NULL
promoter	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9	NULL
:	NULL
4477-4484	NULL
,	NULL
1990	NULL
.	NULL

Downloaded	NULL
from	NULL
www.physiclogy.org/journal/ajplung	NULL
(	NULL
173.236.240.127	NULL
)	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

